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Dopaminergic neurotransmission SPECT studies with 123I-labelled radioligands can 
help in the diagnosis of neurological and psychiatric disorders such as Parkinson’s 
disease and schizophrenia. Nowadays, interpretation of SPECT images is based 
mainly on visual assessment by experienced observers. However, a quantitative 
evaluation of the images is recommended in current clinical guidelines. 
Quantitative information can help diagnose the disease at the early pre-clinical 
stages, follow its progression and assess the effects of treatment strategies. 
 
SPECT images are affected by a number of effects that are inherent in the image 
formation: attenuation and scattering of photons, system response and partial 
volume effect. These effects degrade the contrast and resolution of the images and, 
as a consequence, the real activity distribution of the radiotracer is distorted. 
Whilst the photon emission of 123I is dominated by a low-energy line of 159 keV, it 
also emits several high-energy lines. When 123I-labelled radioligands are used, a 
non-negligible fraction of high-energy photons undergoes backscattering in the 
detector and the gantry and reaches the detector within the energy window. 
 
In this work, a complete methodology for the compensation of all the degrading 
effects involved in dopaminergic neurotransmission SPECT imaging with 123I is 
presented. The proposed method uses Monte Carlo simulation to estimate the 
scattered photons detected in the projections. For this purpose, the SimSET Monte 
Carlo code was modified so as to adapt it to the more complex simulation of high-
energy photons emitted by 123I. Once validated, the modified SimSET code was used 
to simulate 123I SPECT studies of an anthropomorphic striatal phantom using 
different imaging systems. The projections obtained showed that scatter is strongly 
dependent on the imaging system and comprises at least 40% of the detected 
photons. Applying the new methodology demonstrated that absolute quantification 
can be achieved when the method includes accurate compensations for all the 
degrading effects. When the method did not include correction for all degradations, 
calculated values depended on the imaging system, although a linear relationship 
was found between calculated and true values. It was also found that partial volume 






Despite the advantages of absolute quantification, the computational and 
methodological requirements needed severely limit the possibility of application in 
clinical routine. Thus, for the time being, absolute quantification is limited to 
academic studies and research trials. In a clinical context, reliable, simple and rapid 
methods are needed, thus, semi-quantitative methods are used. Diagnosis also 
requires the establishment of robust reference values for healthy controls. These 
values are usually derived from a large data pool obtained in multicentre clinical 
trials. The comparison between the semi-quantitative values obtained from a 
patient and the reference is only feasible if the quantitative values have been 
previously standardised, i.e. they are independent of the gamma camera, 
acquisition protocol, reconstruction parameters and quantification procedure 
applied. Thus, standardisation requires that the calculated values are compensated 
somehow for all the image-degrading phenomena. 
 
In this thesis dissertation, a methodology for the standardisation of the quantitative 
values extracted from dopaminergic neurotransmission SPECT studies with 123I is 
evaluated using Monte Carlo simulation. This methodology is based on the linear 
relationship found between calculated and true values for a group of studies 
corresponding to different subjects with non-negligible anatomical and tracer 
uptake differences. Reconstruction and quantification methods were found to have 
a high impact on the linearity of the relationship and on the accuracy of the 
standardised results. 
 
Besides the aforementioned methodological works based on Monte Carlo 
simulation, the methods presented in this thesis were also applied in research and 
clinical frameworks with real studies from healthy subjects and patients. 
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1.1 The role of functional imaging in the study of the 
dopaminergic neurotransmission 
1.1.1 The dopaminergic system 
The nervous system contains a network of neurons that transmit signals to other 
specific target cells as electrochemical waves through cellular junctions called 
synapses. Synapses may be electrical, establishing a direct connection between 
neurons, or chemical. The neuron that sends the signal is called presynaptic and the 
target cell that receives the signal is called postsynaptic. The synaptic cleft is the 
space between the presynaptic and postsynaptic membranes. 
 
In an electrical synapse, the presynaptic and postsynaptic cell membranes connect 
through special channels called gap junctions that are capable of passing electric 
current very quickly. In a chemical synapse, the presynaptic area contains the 
neurotransmitter which is a chemical that is stored in spherical vessels named 
synaptic vesicles. When the electrical impulse reaches the presynaptic terminal it 
releases the neurotransmitter into the synaptic cleft. Once released from the 
vesicles, the neurotransmitter is bound to the receptors embedded in the 
postsynaptic membrane and activates the cell. Depending on the type of receptor, 
the effect may be excitatory, inhibitory or modulatory. 
 
Dopamine is a neurotransmitter which is implied in brain processes that regulate 
movement and emotional responses, and helps control the brain’s reward and 
pleasure centres. So, dopamine regulation plays a crucial role in mental and 
physical health. Neurons containing dopamine are clustered in the midbrain in an 





area called the substantia nigra and in the ventral tegmental area (VTA). Dopamine 
activates at least five types of dopamine receptors named D1, D2, D3, D4 and D5, and 
it is removed from synapses by a protein called dopamine transporter (DAT). This 
protein, located in the membrane of the presynaptic neuron, sends the dopamine 
back to the vesicles for storage, thus finishing with the signal. Figure 1.1 shows a 
scheme of the dopamine biosynthesis, release and metabolism. 
 
 
Figure 1.1 Scheme of the dopamine biosynthesis, release and metabolism. 
 
1.1.2 Dysfunction of the dopaminergic system in patients with 
Parkinson’s disease and schizophrenia 
Dysfunction of the dopaminergic system has long been implicated in many 
neurological and psychiatric disorders. Of all the brain disorders associated with 
abnormal dopaminergic functioning, the most recognised dopamine-related 
disorder is Parkinson’s disease (PD) and, with less straightforward evidence, the 






















Parkinson's disease (PD) is a progressive degenerative neurological disorder that 
affects muscle movement and control, leading to severe limitations in daily activity 
and quality of life. It is associated with the loss of dopamine-secreting neurons 
projecting from the substantia nigra to the subcortical part of the forebrain called 
the striatum which, as a consequence, presents dopamine depletion (Kish et al 
1988). 
 
The caudate nucleus and the putamen are the striatal structures most associated 
with this pathology. As dopamine relays information between the substantia nigra 
and the areas of the brain that coordinate movements, when there is a shortage of 
available dopamine, the motor symptoms of PD appear. This usually affects people 
around the age of 60, although it can occasionally present at a much earlier age. 
Additional non-motor symptoms of PD may include depression, cognitive, 
behavioural and emotional problems, and sleep disorders. 
 
There is no cure for PD, but various pharmaceutical and surgical treatments can 
help manage symptoms and improve the patient’s quality of life. PD affects 0.5-1% 
of people in the age of 65-69 years and 1-3% of people over the age of 80, and it is 
the second most common neurodegenerative disorder after Alzheimer's dementia 
(Nussbaum and Ellis 2003). Symptoms tend to fluctuate and intensify over time. 
 
The common clinical features shared by patients suffering from movement 
disorders are referred to as parkinsonism. There are different pathologies than can 
cause parkinsonism but PD accounts for around 80% of parkinsonism cases. Thus, 
people with PD classically present the symptoms associated with parkinsonism: 
tremor at rest (in hands, arms, legs, jaw and face), rigidity, bradykinesia (slowness 
of movement), hypokinesia (reduced movement), akinesia (loss of movement) and 
postural abnormalities (Marsden 1994). 
 
The neurodegenerative diseases called Parkinson’s syndromes include PD and 
Parkinson-plus syndromes, also referred to as atypical parkinsonism. The latter is a 
group of neurodegenerative diseases that present the classical features of 
parkinsonism with additional features that distinguish them from PD. They include 
multiple system atrophy (MSA) (Gilman et al 2008), progressive supranuclear palsy 
(PSP) (Brooks 2002) and corticobasal degeneration (CBD) (Mahapatra et al 2004). 
Discrimination of these disorders is a difficult task but it is key to the process of 









Schizophrenia is a complex psychiatric disorder that affects approximately 1% of 
the population (Perälä et al 2007). Manifestations of the illness are commonly 
divided into positive, negative and cognitive symptoms. Positive symptoms include 
abnormalities in the perception or expression of reality such as auditory 
hallucinations, paranoid or bizarre delusions, or disorganised speech and thinking. 
Negative symptoms reflect a diminution or loss of normal functions, and include 
flattened affect, inability to experience pleasure, lack of drive and motivation, and 
social withdrawal (Andreasen and Olsen 1982). Cognitive symptoms comprise 
attention deficits, impaired executive functions such as planning, abstract thinking, 
rule flexibility and memory deficits (Gold and Harvey 1993). Onset of schizophrenia 
typically occurs in early adulthood and is often followed by a chronic and disabling 
course of the disorder. 
 
Studies suggest that genetics, early environment, neurobiology, psychological and 
social processes are important contributory factors (Tsuang 2000, Walker et al 
2004), but the neuropathology of schizophrenia remains unknown. 
 
For many years scientists have suspected the involvement of dopamine, as 
increased dopamine presynaptic activity is consistently found in schizophrenic 
individuals (Reith et al 1994, Hietala et al 1995, Lindström et al 1999). It has been 
proposed that hyperactivity of dopamine transmission is responsible for positive 
symptoms. This hypothesis is based on the fact that a large number of 
antipsychotics have dopamine-receptor antagonistic effects (Seeman and Lee 1975) 
and dopamine-enhancing drugs have psychotogenic effects (Lieberman et al 1987). 
Functional imaging has shown elevated release of dopamine in the striatum of 
schizophrenic patients both at basal conditions (Abi-Dargham et al 2000) and in 
response to amphetamine (Laruelle et al 1996, Abi-Dargham et al 1998). Whilst not 
fully explaining the cause of schizophrenia, it shows the disruption of dopaminergic 
activity that it is observed in this disorder (Howes and Kapur 2009, Lyon et al 
2011). Furthermore, it should be highlighted that the mainstay of treatment is 
antipsychotic medication, whose primarily function is to suppress dopamine 
activity. 
 





1.1.3 Study of the dopaminergic neurotransmission using functional 
imaging 
Non-invasive functional imaging using specific dopamine-related tracers can assess 
functioning at the presynaptic terminals or postsynaptic binding sites. Both 
positron emission tomography (PET) and single photon emission computed 
tomography (SPECT) are suitable for functional imaging.  
 
Presynaptic functioning imaging 
As previously mentioned, the presynaptic dopaminergic function is associated with 
DAT. DAT is the protein that controls the intensity and duration of dopaminergic 
neurotransmission by re-uptaking dopamine from the synaptic cleft (see figure 1.1) 
(Amara and Kuhar 1993, Giros and Caron 1993, Jaber et al 1997). Thanks to 
different studies and investigations, we now know that a reduction in the number 
of DATs denotes a reduction of the nigrostriatal dopamine function, which in turn 
decreases dopamine levels in the striatum (Uhl et al 1994, Counihan and Penney 
1998, Bezard et al 2001). Thus, DAT density can serve as an imaging biomarker for 
diagnosing PD. 
 
A number of cocaine analogues labelled with gamma-emitter radionuclides that 
bind to DAT sites have been developed for SPECT imaging of the dopaminergic 
system (Neumeyer et al 1994, Tatsch 2001, Halldin et al 2001, Johannsen and 
Pietzsch 2002). As the radiolabelled compound joins the DAT, the activity 
concentration in the striatum becomes an indicator of the DAT concentration. 99mTc 
and 123I have been used for the study of the presynaptic dopaminergic function in 
SPECT studies. 123I-FP-CIT, under the commercial name of DaTSCAN (GE 
Healthcare, UK), is the radiopharmaceutical currently used for DAT SPECT imaging. 
Due to its availability, cost and clinical results, neurotransmission SPECT imaging 
has now become a common tool in the in vivo study of presynaptic dopamine 
function in PD (Frey 2002, Huang et al 2003). DaTSCAN plays a major role in 
differentiating PD patients from patients with essential tremor (ET), since 
dopamine is depleted in PD patients but not in ET patients (Benamer et al 2000). 
DAT SPECT imaging has also been used to study the relationship between 
schizophrenia and DAT binding but results are still inconclusive (Laruelle et al 
2000, Mateos et al 2005, Schmitt et al 2005). 
 





An analogue of levodopa (L-DOPA), which is the immediate precursor of dopamine 
and it is used in the treatment of PD, is labelled with 18F for PET scans of the striatal 
dopaminergic presynaptic function. 18F-DOPA reflects the activity of the 
decarboxylating enzyme that generates dopamine from L-DOPA and the storage 
capacity of dopamine (Brown et al 1999). Studies suggest that in the early stages of 
PD, dopamine synthesis rate might be up-regulated as a compensatory 
phenomenon. Consequently, the uptake of 18F-DOPA may be normal even in 
parkinsonian patients. In contrast, DAT is down-regulated, making 123I-FP-CIT more 
sensitive for the early detection of PD (Zigmond MJ et al 1990). For economic 
reasons, 18F-DOPA is less frequently used than 123I-FP-CIT for monitoring the 
progression of the disease. In schizophrenia, studies using 18F-DOPA and 11C-DOPA 
have evidenced an overactivity of presynaptic dopamine in the striatum (Reith et al 
1994, Hietala et al 1995, Lindström et al 1999, Kumakura et al 2007, Bose et al 
2008). 
 
Postsynaptic functioning imaging 
SPECT and PET imaging can also be used to assess dopamine receptor binding. 123I-
IBZM (GE Healthcare, UK) is the most common radiopharmaceutical for imaging D2 
postsynaptic receptors in SPECT. It is used to differentiate PD patients from 
Parkinson-plus syndromes patients (Marshall and Grosset 2003, Gerasimou et al 
2005, Plotkin et al 2005). The equivalent radiotracer for PET is 11C-Raclopride 
(Catafau et al 2009). In schizophrenia, dopamine receptor availability in drug-naive 
or drug-free patients has been studied using functional SPECT and PET and no 
significant alterations in striatal D2 receptors that would indicate a D2 receptor 
abnormality in this disease were found (Lomeña et al 2004, Talvik et al 2006). 
 
Functional imaging is used in pharmacology for the development of antipsychotic 
drugs. Drugs are labelled with selective radioligands such as 123I-IBZM and 11C-
Raclopride to obtain SPECT and PET studies of the postsynaptic D2 dopamine 
receptors. These studies provide information about the degree of receptor 
occupancy, the minimum effective dose and the duration of the drug action 











1.1.4 The role of dopaminergic imaging in clinical diagnosis 
Diagnosis of neurological and psychiatric diseases associated with disturbances of 
the dopaminergic system provide many challenges. Several symptoms are common 
to different disorders, making a straightforward clinical diagnosis difficult to 
ascertain, particularly in the early stages of the disease. What is more, many 
disorders do not have definite causes or do not have specific biomarkers or tests 
that allow a differential diagnostic. Thus, diagnosis requires the patient’s complete 
medical history together with physical and neurological examinations. 
 
Patients with parkinsonism 
There is no definitive test for identifying PD in patients and so diagnosis is based on 
clinical criteria that range from the presence of pre-motor clinical signs such as 
olfactory loss, rapid-eye-movement sleep behaviour disorder (RBD), somnolence, 
and late age onset anxiety and depression, to the presence of motor symptoms. In 
the early stages of the disease, clinical signs may be subtle or can be confused with 
other Parkinson’s syndromes. Furthermore, clinical diagnosis can be influenced and 
complicated by symptomatic medication. Early and accurate diagnosis of PD is 
important for correct prognostication and management and avoidance of 
unnecessary medical examinations and therapies. Dopaminergic 
neurotransmission functional imaging may assist diagnosis. 
 
Diagnosis using functional SPECT and PET imaging is primarily based on visual 
assessment by experienced observers (Benamer et al 2000). Functional imaging of 
the presynaptic dopaminergic system discriminates patients with PD from healthy 
subjects by identifying dopaminergic deficits in caudate and putamen with high 
specificity and sensitivity (Weng et al 2004, Eshuis et al 2009). The shape of the 
striatum and its completeness offers valuable information about left or right 
asymmetric radiopharmaceutical uptake, as the loss of the dopaminergic neurons 
starts ipsilaterally, on the contralateral side to the symptoms (Asenbaum et al 
1997). SPECT images of healthy volunteers show similar, uniform uptake in caudate 
and putamen which make the whole striatum present a “comma-shaped” form 
(figure 1.2b). The neurological degeneration that takes place in PD makes the 
striatum lose its shape and become, in severe cases, “point-like” (figure 1.2c). 
Reduction of striatal uptake is more profound in advanced stages than in the early 
stages of the disease. 
 





       
a   b     c 
Figure 1.2 Slice from a magnetic resonance imaging (MRI) scan showing the caudate nucleus and 
the putamen delineated in blue a; slice of a neurotransmission SPECT study of a healthy subject 
b; slice of a neurotransmission SPECT study of a patient suffering from PD at an advanced stage 
of the disease c. Note that in c, the intensity of the image has had to be increased to obtain 
uptake values comparable to b.    
 
In clinically uncertain cases, presynaptic dopaminergic imaging may assist in 
discriminating between neurodegenerative parkinsonism and its mimics, since 
non-neurodegenerative patients, such as patients with ET, show a tracer uptake 
similar to healthy controls (Catafau and Tolosa 2004). However, DAT imaging 
cannot help differentiate PD from atypical parkinsonian syndromes, since both are 
associated with presynaptic dopaminergic deficiency (Varrone et al 2001). In 
contrast, postsynaptic D2 receptor imaging can help differentiate between PD and 
atypical parkinsonism since patients suffering from PD usually show normal or up-
regulated D2 receptor binding while patients with atypical parkinsonism show 
reduced binding (Schreckenberger et al 2004). 
 
Patients with schizophrenia 
In recent decades, empirical evidence from post-mortem, in vivo neuroimaging, 
neurochemical and neuropsychological studies have confirmed structural 
abnormalities, biochemical abnormalities and impairments in brain functioning in 
patients with schizophrenia. Specifically, alterations in the dopaminergic system 
have been long implicated in schizophrenia. Dopaminergic imaging could provide a 
key to the understanding of the dysfunction of the dopaminergic system in patients 
with schizophrenia as well as serve as a diagnostic tool. Nevertheless, the results 
found so far are still discordant, in part due to the clinical heterogeneity of the 
disorder. For this reason, current diagnosis of schizophrenia is still based on 





behavioural observations by clinicians and self-reports by the patients about their 
abnormal mental experiences. 
 
1.2 Quantitative evaluation of dopaminergic imaging in 
SPECT 
Dopaminergic neurotransmission SPECT functional images contain valuable 
information about quantitative distribution of the radiotracer in the striatum. As 
previously mentioned, the clinical evaluation of this information is normally based 
on visual assessment but it would be beneficial to have a quantitative assessment 
wherever possible. Quantitative information can help diagnosis together with 
descriptive findings. Besides being observer-independent, quantification is 
especially valued in early diagnosis of the disease at pre-clinical stages (Booij et al 
1999), for staging of the patient, for therapeutic management and in follow-up 
(Buvat 2007). Quantification is, therefore, one of the main topics of research in 
medical imaging today. Functional images can establish normal or disease-related 
states, and indicate response to treatment. 
 
The radiotracer distribution as it appears on the images is affected by a number of 
non-desirable effects that are inherent in the image formation: attenuation, the 
scattered photons detected, the system response and the partial volume effect 
(PVE). As a consequence, the contrast and resolution of the images are degraded 
and the real activity distribution of the radiotracer is distorted. For some time now, 
a large number of studies have been devoted to the development of accurate 
corrections for these degradations and, until now, the area has been an intensive 
field of research for SPECT studies. Accurate corrections may require multimodal 
imaging and the use of simulation techniques with calculation times which are 
difficult to incorporate into clinical routine. Thus, a truly accurate correction of all 
the degrading factors is, for the time being, limited to academic studies (Cot et al 
2005, Crespo et al 2008) and research trials. 
 
In any case, a semi-quantitative evaluation of the images is highly recommended in 
clinical routine. Wherever possible, nuclear medicine practitioners employ 
dedicated software to elicit numerical information from the images and calculate 
different semi-quantitative ratios between regions with specific uptake (caudate 
and putamen) and regions with non-specific uptake (reference areas). Evaluation of 
the calculated ratios is performed by comparing those values corresponding to 
(preferably) age-matched normal controls obtained using the same imaging system 





and the same acquisition, reconstruction and quantification protocols. The 
quantitative information obtained this way is reproducible, observer-independent 
and can help clinical diagnosis along with visual assessment, making semi-
quantitative evaluation more and more necessary in clinical protocols. 
 
A major drawback of this practice is that semi-quantitative results from different 
cameras, or from the same camera but under different acquisition, reconstruction 
or quantification protocols, cannot be compared directly. Standardised values, 
independent of the different imaging set-ups used, can be obtained by 
compensating somehow for all the degrading effects so as to recover the true 
original ratios (El Fakhri et al 2001, Soret et al 2003). 
 
In recent works using anthropomorphic phantoms, a linear relationship between 
measured and true values has been found for a single subject. Some research 
groups use this relationship to standardise their results (Varrone et al 2013), 
although its applicability to any other subject or group of subjects has not yet been 
clearly argued nor demonstrated (Gallego et al 2015). Assuming that this 
methodology proved to be suitable, standardised values could be achieved in a 
straightforward manner. 
 
Standardisation is essential for the creation of large data bases from multicentre 
studies with reference values for normal and pathological stages. This database 
would make it possible to derive robust conclusions about age effects and gender 
differences, for example. A simple methodology for the standardisation of the semi-
quantitative values derived from SPECT neuroimaging is crucial for the accurate 








2  Aim of the thesis 
 
2.1 Statement of the problem 
SPECT allows evaluating the functionality of the nigroestriatal dopaminergic 
system, which is of great interest in PD and schizophrenia. In order to help 
diagnosis, quantification is recommended. However, accurate quantification of 
SPECT images is impaired by a number of degrading factors such as attenuation, 
scattered photons, system response and partial volume effect. 
 
The development of methodologies that can compensate these degrading effects 
requires a tool which allows an evaluation of the performance of the implemented 
method. Monte Carlo (MC) simulation makes it possible to generate SPECT 
projections from known activity distributions. Since the ground truth is known, MC 
simulation allows us to evaluate the reconstruction algorithms, the compensations 
that have been included, and the quantification methods applied. In order to obtain 
reliable results in the evaluation, the suitability of the selected MC code for the 
simulation of the SPECT studies is crucial. 
 
There are several dedicated MC codes for SPECT imaging (Buvat and Castiglioni 
2002). One of these codes, SimSET (Haynor et al 1991), uses a collimator/detector 
response to reduce the simulation time spent in tracking photons through the 
collimators. In particular, it uses an analytical function which only considers the 
geometric response of the collimator. This simplification is valid when simulating 
low-energy photons, such as the 140 keV corresponding to the mono-energetic 
emission from 99mTc or the 159 keV line from 123I (with a yield of 97%). However, 
for the high-energy photons emitted by 123I (3%), which have energies between 248 
and 783 keV, this simplification leads to inaccurate simulations, since septal 





penetration and scatter within the collimator and in the backscatter compartment 
(De Vries et al 1990) cannot be neglected. Other MC codes reproduce the 
contribution to the projections of high-energy photons by tracking photons in the 
collimator but with unacceptably long calculation times. Thus, there is a clear need 
for a model that allows the rapid and realistic simulation of the contribution of 
high-energy photons in SPECT studies using 123I. 
 
Several reconstruction algorithms which include corrections for the degrading 
phenomena have already been developed for the absolute quantification of SPECT 
studies with 99mTc (Beekman et al 2002, Cot et al 2005). However, when 123I-
labelled radioligands are used, the scatter correction becomes more complex due to 
the additional contamination caused by the high-energy emission from 123I. This 
highlights the need for a specific methodology for the absolute quantification of 123I 
SPECT studies of the dopaminergic system that includes an accurate correction of 
the high-energy scatter component. Such an approach permits the study of different 
degrading phenomena that have an effect on SPECT imaging, assessing their 
individual influence, both visually and quantitatively, and evaluating the 
reconstruction methods applied. Due to its high degree of complexity and 
computational burden, this methodology is basically applied to research trials. 
 
In a clinical context, reliable, simple and rapid methods are needed to quantify the 
studies. Absolute quantification has computational and methodological 
requirements which hamper its application in clinical routine. Thus, semi-
quantitative methods are used. Diagnosis assessment also requires the 
establishment of robust reference values for healthy controls. These values are 
usually derived from a large data pool obtained in multicentre clinical trials, so that 
the semi-quantitative values obtained from a patient can be compared with the 
reference. However, this comparison is only feasible if the quantitative values have 
been previously standardised, i.e. they are independent of the gamma camera, 
acquisition protocol, reconstruction parameters and quantification procedure 
applied. Standardisation requires that the calculated values derived from the 
images are compensated somehow for all the image-degrading phenomena. 
 
2.2 Aim 
The aim of this thesis was to provide a methodology that allowed the accurate 
quantification of dopaminergic neurotransmission SPECT studies when 123I-





labelled radioligands are used. The study was developed considering the two 
contexts where quantification is required, i.e. research and clinical routine. 
 
To this end the following specific objectives were established: 
 
1. Adaptation and validation of the Monte Carlo simulator SimSET for SPECT 
studies with 123I which includes both low and high-energy emissions. 
 
2. Development and validation of a complete methodology for the absolute 
quantification of dopaminergic neurotransmission SPECT studies with 123I 
to be applied in research trials. 
 
3. Development and validation of a straightforward methodology for the 
standardisation of the semi-quantitative values extracted from 
dopaminergic neurotransmission SPECT studies with 123I which can be 
applied in clinical routine. 
 
2.3 Contents of the thesis 
This thesis starts with an introduction to the study of the dopaminergic system 
using functional imaging and its role in the clinical diagnosis of Parkinson’s disease 
and schizophrenia (chapter 1). In this context, the aim is established and three 
specific goals are determined to fulfil the main objective of this doctoral 
dissertation (chapter 2). The background information about acquisition, data 
processing and the use of Monte Carlo simulation in SPECT imaging is described in 
chapter 3. Next, each of the three specific goals of the thesis is explained, 
methodologically addressed and developed in turn (chapters 4, 5 and 6), one per 
objective. Thus, chapter 4 describes the changes introduced to the MC code SimSET 
to adapt it to the simulation of 123I SPECT studies and demonstrates its validity, 
chapter 5 presents and validates a methodology for the absolute quantification of 
123I SPECT studies of the dopaminergic neurotransmission system to be applied in 
research trials, and chapter 6 proposes and validates an alternative methodology to 
achieve standardised results from the semi-quantitative values extracted from 
dopaminergic neurotransmission SPECT studies with 123I-labelled radioligands 
which can be applied in clinical routine. In addition, the contribution of these 
methodologies in several clinical works proposed and developed by other 
researchers in the fields of PD and schizophrenia is discussed in chapter 7. Finally, 
chapter 8 provides the concluding remarks. 


















3 Acquisition, data 
 processing and  Monte 
 Carlo simulation in 
 SPECT imaging 
 
3.1 Data acquisition 
A SPECT neuroimaging study starts with the intravenous administration of a 
radiotracer to the patient. The radiotracer consists of a gamma-emitter 
radionuclide together with a ligand, which leads the radionuclide to the region of 
the body under study. Following a time delay after injection, photons emitted from 
the radiotracer start to be detected in vivo by a rotating gamma camera which 
acquires a set of 2D planar projections at evenly spaced angles around the patient 
over a full 360° arc (Anger 1958). Figure 3.1 shows one of the SPECT gamma-
cameras installed at Hospital Clínic of Barcelona (Barcelona, Spain). 
 
In dopaminergic SPECT imaging of the presynaptic function, the 
radiopharmaceutical injected into the patient is a cocaine analogue which binds to 
DAT. Postsynaptic levels can also be targeted by SPECT tracers that bind to the 
postsynaptic D1 and D2 receptors. The radionuclides most widely used in SPECT 
neuroimaging are 99mTc and 123I. 99mTc has a simple decay scheme with a low-
energy photon emission of 140 keV, while 123I emission is dominated by a low-





energy photon emission of 159 keV (97%) and other emission lines of higher 
energies up to 783 keV (3%). 
 
 
Figure 3.1 SPECT gamma camera (Hospital Clínic of Barcelona). 
 
A gamma camera consists of several (from one to three) detector heads containing 
a collimator and a scintillation detector with position logic circuits, and a data 
analysis computer. The detector heads are attached to a gantry for motion control. 
Each detector head is shielded from background radiation leaving a large open 
detection area (typically 25x50 cm) where the collimator and a thin NaI(Tl) crystal 
are located (see figure 3.2). Only triple or dual head dedicated SPECT gamma 
cameras are recommended for brain imaging. 
 
 
Figure 3.2 Components of the detector head of a gamma camera. The tracer emits radiation 












The collimator sets the acceptance angle for the detection of the emitted photons. It 
consists of a pattern of several tens of thousands of holes perforating a slab of lead. 
The holes are a few centimetres long and a few millimetres in diameter, usually of 
hexagonal shape. The lead walls between the holes are called septa. As few photons 
are capable of going through the lead septa, projections mainly correspond to those 
photons which have travelled along the holes. The hole diameter, the collimator 
thickness and the septal thickness have a direct impact in the sensitivity of the 
collimator. The collimator ensures that the direction of the detected photons is well 
known, but it drastically reduces the sensitivity of the gamma camera, i.e. the 
number of detected photons divided by the number of emitted photons, which is 
typically around 10-4. 
 
Brain SPECT imaging is often performed with parallel and fan-beam collimators. In 
parallel collimators, the holes are perpendicular to the plane of the lead plate and 
parallel to each other. Thus, the image and the object have the same size. In fan-
beam collimators, the holes are parallel to each other in the y-axis but not in the x-
axis, as it is shown in figure 3.3. In such geometrical configuration, the holes point 
towards a focal line which is parallel to the collimator plane. In this case, the image 
is augmented in the x-direction. 
 
 
Figure 3.3 Different collimator configurations used in brain SPECT imaging: (left) parallel 
collimator and (right) fan-beam collimator. 
 
The detector of the gamma camera is generally a NaI(Tl) crystal of about one 
centimetre thick. This crystal presents optimal detection efficiency for the energy 
range used. Photons interact with the crystal by means of photoelectric effect or 
Compton scattering and produce light in proportion to the energy deposited in the 
crystal in a process known as scintillation. Light is then led to an array of 
photomultipliers (PM) tubs by a glass light guide. The PM-tubs convert the light 
photons into electrons, amplify the number of electrons and convert them into an 
electrical pulse. Pulses are processed through position logic circuits which allow 





the localization of the detection in the crystal. Finally, the detected photon is 
accepted or rejected depending on its energy. As the energy resolution of the 
detector is around 10% for energies ranging from 100 to 200 keV, the energy 
detection window is usually fixed at around 15-20% of the photopeak energy of the 
gamma-emitter radionuclide. 
 
The position of the detected photon is incorporated into a digitalised image which 
has been divided into a grid. Each square of the grid (known as “bin”) constitutes an 
element of the matrix that holds information on the number of detections 
registered on each element. In neuroimaging, the size of the matrix is set to 128 x 
128 bins. The total information stored constitutes a projection of the object on the 
detector plane. 
 
The acquired projections are finally reconstructed with a processing computer 
which applies tomographic reconstruction algorithms to obtain the volumetric 3D 
distribution of the tracer inside the body. In order to obtain the reconstructed 
image, projections have to be acquired at a sufficient number of angles. In SPECT 
neuroimaging, 120 or 128 projections over 360° are acquired depending on the 
gamma camera used. The scan time is set to acquire more than 3 million total 
counts, which takes about 40 minutes. The distance between the detection heads 
and the patient, i.e. the rotational radius, is set to be the smallest possible with 
appropriate patient safeguards.  
 
3.2 Image degrading effects 
SPECT projections are severely affected by a number of non-desirable effects that 
degrade the quality of the images. The most important effects are: statistical noise, 
attenuation of the photon flux, improper detection of the scattered photons and 
collimator/detector blurring. These image degrading effects result in poor spatial 
resolution, low contrast and high noise levels in the images, and may have a large 
impact on quantitative accuracy if left uncorrected. In the following sections, a 
description of each degrading effect is given. Figure 3.4 synthesizes the events that 










Figure 3.4 An emitted photon can be: attenuated by the surrounding tissues by means of 
photoelectric (A) or scatter interactions (B), detected after scattering (C), absorbed by the 
collimator septa (D), and, detected after travelling along the holes (E and F) or after penetrating 
the collimator septa (G). 
 
3.2.1 Statistical noise 
Since the radiotracer photon emission follows a Poisson probability distribution, 
SPECT projections are certainly affected by statistical noise. 
 
Signal-to-noise ratio (SNR), which is the ratio between the mean counts and the 
noise at each bin of the projection, can be improved using longer acquisition times, 
higher dose administrations or by increasing the number of detectors and the size 
of the bin. However, none of these are appropriate or technically possible in a 
clinical context. A longer study time increases patient discomfort and the possibility 
of movement, as well as reduces the number of patients that can be attended per 
day. Radiotracer doses are limited due to radiological protection criteria. The 
number of detection heads in the gamma camera is technically limited to three and 


















3.2.2 Attenuation of the photon flux 
The photon flux is attenuated by the patient media on its way to the detector. As 
shown in figure 3.5, photons may be absorbed by photoelectric absorption (photon 
A) or scattered (photon B) in such a way that they will not become part of the 
projection. Thus, attenuation causes a non-uniform decrease in the signal, which 
will vary depending on the length and tissues that each photon has to go through as 
well as on the photon's energy. 
 
 
Figure 3.5 Impact of attenuation on SPECT imaging: photon A is attenuated by photoelectric 
absorption, while photon B suffers Compton scattering and it is not detected. As a result there is 
a decrease in the number of counts in the projection data (solid line) with respect to the ideal 
SPECT imaging (dashed line).  
 
For photons emitted with energies between 50 keV and 1000 keV, the most 
probable interaction with matter is Compton scatter. At lower energies (below 100 
keV) and for materials such as the lead walls of the collimator, photoelectric 
absorption is also relevant. Coherent scatter (Rayleigh scatter) can be the dominant 
interaction at small angles of scatter (Kaplan et al 1998). Thus, in brain SPECT 
studies, attenuation is mainly due to Compton scatter and to some photoelectric 
absorption. 
 
A mono-energetic beam of photons 𝐼 passing through a non-uniform medium of 
thickness d is attenuated according to the following equation: 
 





𝐼 = 𝐼0 · 𝑒𝑥𝑝  − 𝜇 𝑥 𝑑𝑥
𝑑
0
  (3.1) 
 
Where 𝐼0  stands for the incident photon flux and 𝜇 is the linear attenuation 
coefficient of the material, which depends on the photon energy. In SPECT 
neuroimaging 𝜇 values for brain and bone are 0.143 cm-1 and 0.304 cm-1 for 99mTc, 
and 0.149 cm-1 and 0.307 cm-1 for the low-energy emission from 123I, respectively. 
Thus, bone causes stronger attenuation than brain. Attenuation is also more 
probable for those photons originated in inner tissues. Attenuation results in 
regions with the same activity distribution making a different contribution to the 
projection. 
 
3.2.3 Scattered photons detected 
Photons which have undergone scatter before detection are an important source of 
haziness in the projections as they are tracked back incorrectly during 
reconstruction. As a consequence, the contrast of the reconstructed images is 
affected and quantitative accuracy is degraded. The impact of scatter in the 
projections is illustrated in figure 3.6. 
 
 
Figure 3.6 Impact of scatter on SPECT imaging: the addition of the scattered photon A leads to its 
incorrect location in the projection (solid line) with respect to the ideal SPECT imaging (dashed 
line). 
 





If narrow energy detection windows are used, the amount of scattered photons can 
be reduced during the acquisition. The energy window is centred on the energy of 
the dominant emission and has a width which depends on the system’s energy 
resolution. Usually, energy detection windows are set to 15-20% of the photopeak 
energy. When 123I-labelled radiotracers are used, a fraction of the high-energy 
photons emitted reach the detector crystal within the energy window. This is 
possible due to the interactions that these photons undergo at the backscatter 
compartment of the detector. Thus, an important part of the detected photons in 
the projections would have suffered scatter. 
 
3.2.4 The spatially variant collimator/detector response 
Another source of degradation is the finite, distance-dependent spatial resolution of 
the imaging system. As shown in figure 3.7, the image of a point source in air 
through the collimator/detector system is a 2D distribution. This distribution is 
called the point spread function (PSF) and its width is the spatial resolution of the 
system. PSF depends on the geometrical characteristics of the collimator, the 
intrinsic resolution of the detector, the energy of the incident photon and the 
distance from the collimator. PSF can be described by two variables: sensitivity, 
which is the number of photons detected per emitted photon, and resolution, which 
is defined as the full width half maximum (FWHM) of the planar projection of a 
point source. Resolution has two components, the collimator resolution and the 
intrinsic resolution of the detector and electronics.  
 
 
Figure 3.7 PSF of a point source at different distances. 





Collimator resolution is illustrated in figure 3.8. In this figure, both photon A, which 
is emitted parallel to the s-axis, and photon B, which is angled relative to the s-axis, 
are geometrically accepted through the holes of the collimator. 
 
 
Figure 3.8 Impact of the spatial resolution of the imaging system on SPECT imaging: both photon 
A, which is emitted parallel to the s-axis, and photon B, which is angled relative to the s-axis, are 
geometrically accepted through the holes of the collimator contributing to the same projection 
bin (solid line). 
 
The collimator design plays a major role in the sensitivity and resolution 
compromise. Smaller holes improve resolution but decrease sensitivity. Since 
collimator resolution also depends on the distance between the source and the 
camera, detector heads are positioned as close as possible to the patient. In brain 
SPECT imaging, resolution is the main objective because of the small volume of the 
structures. Thus, Low-Energy High Resolution (LEHR) parallel and fan-beam 
collimators characterised by small hole diameters are used. Although parallel 
collimators are the most widely used in SPECT, fan-beam collimators are especially 
indicated for brain SPECT as they provide greater count rate capability and a wider 
area of detection while retaining a reasonable resolution. 
 
3.2.5 Other image degrading effects 
Other image degrading effects, of minor relevance compared to the phenomena 
highlighted above, are associated with non-linearity and non-uniformity of the 





detector and the inaccuracy of its centre of rotation, and these can usually be 
corrected by the camera software. On the other hand, biological factors such as the 
tracer kinetics and target specificity and more importantly, patient and organ 
movement, have a disturbing effect which has recently become of great concern as 
quantification gets more accurate (Koch et al 2007a). As in SPECT neuroimaging 
there is no internal organ motion, patient movement can be reduced by the use of 
head restraints.   
 
3.3 Image reconstruction  
The projections acquired by the gamma camera need to be reconstructed to obtain 
the volumetric distribution of the source inside the patient. The final image is 
obtained using mathematical algorithms which process and reconstruct the 
projection data set on a computer.  
 
Until now, filtered back projection (FBP) has been the most widely used 
reconstruction technique in clinical routine. Nevertheless, an alternative 
methodology, iterative reconstruction, is gaining popularity since it is being 
included in most SPECT camera software packages. It is in research, however, 
where the particularities of iterative reconstruction are exploited most. The main 
advantage of iterative reconstruction is that it allows including accurate 
information about the object and the gamma camera in the algorithm, so images 
can be compensated for the degrading phenomena. Unfortunately, the modelling of 
these effects is much demanding in terms of processing time than FBP. 
 
3.3.1 Filtered back projection 
FBP reconstruction provides an exact, analytical solution to the ideal problem of 
reconstructing the source from geometrical projections, i.e. when no degradations 
are involved in the process. Its popularity is mainly due to its simplicity and to the 
fact that the reconstruction time needed is very short. The value in each pixel of the 
image is calculated as the sum of the values of all the bins of the acquired 
projections that can receive photons from that pixel divided by the number of 
projections. Back projection takes into account the fact that the contribution of a 
given pixel to a given bin depends on their relative positions and acquisition angle.  
 





FBP is based on the central section theorem, which relates the 1D Fourier 
transform of the projections with the 2D Fourier transform of the image evaluated 
on the line that the projection was taken. FBP turns to be the convolution product 
between the projection and a ramp filter. The aim of the ramp filter is to recover the 
high frequencies which have been attenuated in the back projection process. 
Uniform images or with soft changes would be characterised by low frequency 
components while details or strong changes would need high frequencies to be 
represented properly.  
 
In a real case, FBP produces noisy images which show a streak artefact because 
image degradations are not considered and because the number of projections is 
finite. In order to improve the reconstructed images, compensations for the 
degrading effects have to be applied. 
 
Improving image signal-to-noise 
Noise has high frequency components that are strengthened in FBP reconstruction 
due to the ramp filter. It is therefore necessary to apply additional low-pass filters 
to smooth the images, although these will affect the spatial resolution. One of the 
filters most frequently used to improve noise is the Butterworth filter: 
 






2𝑛    (3.2) 
 
Where 𝑤𝑐  is the cut-off frequency, i.e. the frequency above which the noise is 
eliminated, and 𝑛 is the order of the filter and controls the slope of the function. 
Thus, a high order will result in a sharp decrease. The cut-off and order of the filter 
will depend on the protocol of the centre and their selection is a trade-off between 
resolution and noise. 
 
Attenuation correction 
The Chang algorithm is the methodology most commonly used in clinical routine to 
correct attenuation after FBP reconstruction (Chang 1978, 1979). Chang’s method 
consists in a post-reconstruction correction which seeks to compensate for 
attenuation by multiplying each point in the body by a correction factor. The 
correction matrix is generated using a homogeneous linear attenuation coefficient 
of 0.10-0.12 cm-1 for 123I and 0.12-0.14 cm-1 for 99mTc. The value of the coefficient 





depends on whether the acquired projections have been previously corrected for 
scatter or not. In the absence of scatter correction, the lowest values are selected. 
For each transaxial slice, the shape contour of the brain including the scalp should 
be defined or, if this is not available, some kind of approximation. In any case, this 
correction can only be a rough approximation, since it is only reasonable for a point 
source surrounded by a homogeneous medium.   
 
PSF correction 
PSF can be approximately corrected by applying a Metz filter (Metz and Beck 1974, 
Metz et al 1980), but this is not usual. 
 
Scatter correction 
There are many approaches for correcting scatter but, in general, all methods can 
be classified into two groups: those based on measurements, i.e. applying empirical 
methods that involve the direct measurement of the scatter fraction present in the 
projections, and those based on the modelling of the scatter distribution. 
 
In clinical routine, only very basic scatter correction methods are used (Hutton et al 
2011). The empirical method most widely used to estimate the scattered fraction in 
acquired projections is the Triple Energy Window (TEW) (Ogawa et al 1991, 
Ichihara et al 1993). This method is based on the energy spectrum data and 
consists of using two additional energy windows during the acquisition. The 
additional windows are relatively narrow and are placed at each side of the 
photopeak to achieve a good estimation of the scatter distribution and a realistic 
estimate of the amount of scattered photons detected. The primary fraction in each 
projection bin is estimated by correcting the detected photons in the photopeak 
window by the mean value of the lateral windows. Its advantages of speed and 
simplicity have lead to TEW being adopted as a standard scatter correction. More 
sophisticated multi-windows methods have since been developed (Haynor et al 
1995), but they have not demonstrated a clear advantage over TEW (Assié et al 
2010). 
 
Far more frequently, scatter is compensated during reconstruction rather than 
corrected in the projections. This compensation involves applying an effective 
linear attenuation coefficient in the Chang’s method. Its value, which is lower than 
that used when projections have been corrected for scatter, seeks to compensate 





for both attenuation and scatter phenomena within the object. The coefficient is 
calculated to under correct the primary photons of the projections in such a way 
that the reconstruction of a cylinder with uniform activity distribution results in a 
uniform image. 
 
3.3.2 Iterative reconstruction 
The accuracy of the images improves if all the degrading effects that occur during 
the acquisition are modelled in the reconstruction algorithm. Iterative 
reconstruction can carry out this modelling but it requires long computational 
times. Thus, until recently, iterative reconstruction was limited to research. 
Nowadays, access to more powerful computers as well as the appearance of 
accelerated codes is starting to bring iterative algorithms within clinical reach. 
However, the accurate modelling of most degradations requires methodologies that 
are still too complex to be implemented in clinical routine and so they are only 
found in research trials. 
 
Iterative reconstruction proposes a probabilistic interpretation of the problem 
which is suitable due to the stochastic nature of the radioactive decay process. In 
iterative algorithms, an initial estimate of the activity distribution is used to 
generate the estimated projections, for example, a uniform image or an image 
obtained by FBP. The generated projections are then compared with the real 
acquired projections. As a next step, the result of this comparison is used to update 
the estimation of the activity distribution. The process of forward projection, 
comparison and updating continues iteratively until the errors achieve a predefined 
value or the maximum number of iterations is reached. Iterative algorithms use a 
transition matrix to model the forward projection. An accurately modelled 
transition matrix leads to more realistic estimations of the activity distribution. 
 
Among the different iterative algorithms, Maximum Likelihood Expectation 
Maximization (ML-EM) (Shepp and Vardi 1982, Lange and Carson 1984) is the most 
commonly used for SPECT. The advantages which have contributed to its 
popularity are its good theoretical base and its convergence (Chornoboy et al 
1990). ML-EM seeks to find a general solution that is the best estimate for the 
activity distribution, i.e. the mean number of radioactive disintegrations in the 
image that can produce the acquired projections with the highest likelihood. ML-
EM algorithm updates all the voxels in the image  𝜆𝑖  using the following expression: 


















𝑗=1   (3.3) 
 
Where 𝜆𝑖
𝑘+1  is the image new estimation at iteration 𝑘 + 1; 𝑡𝑗𝑖  represents the 
transition matrix, which are the probabilities that a photon emitted in voxel 𝑖 
contributes to the projection bin 𝑗; 𝑝𝑗  represents the measured projections; and 
 𝑡𝑗𝑚 · 𝜆𝑚
𝑘
𝑚  is the projection bin 𝑗 after forward projection of the image estimation 
at iteration 𝑘. Although accuracy improves with each iteration, random noise also 
increases at each computation step. It is therefore important to establish the 
number of iterations needed to reach the image quality or quantitative parameters 
required by the user. 
 
ML-EM is so slow that this scheme is almost always accelerated by the most widely 
used accelerating technique, the ordered subsets algorithm (OS). This algorithm, 
which was introduced by Hudson and Larkin in 1994, was added to the EM 
algorithm, resulting in the Ordered Subsets Expectation Maximization (OS-EM). The 
acceleration given by the OS algorithm comes from grouping the projection data 
into an ordered sequence of subsets. EM algorithm is then applied to the first 
subset of projections and the result is considered to be the starting estimate of the 
next subset. This acceleration does not degrade the quality of the images but 
reduces the computational time needed by a factor which is proportional to the 
number of subsets used (Kamphuis et al 1996). This acceleration leads to clinically 
acceptable reconstruction times, allowing its introduction in routine use for 
selected applications instead of FBP (Koch et al 2006, Catafau et al 2008). 
 
Fully 3D reconstruction is necessary to accurately model photon crosstalk between 
transaxial slices. However, the problem can be simplified to 2D reconstructions by 
considering each tomographic section of the image individually. 2D approximations 
are favoured for clinical routine primarily because 3D reconstructions, although 
improving the quality of the reconstructed images, require a larger matrix together 
with major computational considerations (Guilland et al 1994). 
 
The transition matrix 
The transition matrix 𝑇 models the forward projection and re-projection. Each 
element of this matrix stands for the probability that a photon originated in the 
voxel 𝑠𝑖  of the activity distribution image is observed in the projection bin 𝑝𝑗 . The 
transition matrix is generated based on the relative geometric positions between 





the emitter voxels and the detector bins, and considering an ideal projection of the 
object, i.e. supposing perfect collimation and detection. 
 
The transition matrix has a number of columns equal to the number of voxels in the 
image and a number of rows equal to the number of bins in the projection. Given an 
activity distribution 𝑠, the projection data 𝑝 can be estimated by using the 
transition matrix: 
 
 𝑇𝑗𝑖𝑖 · 𝑠𝑖 = 𝑝𝑗  (3.4) 
 
This process of mathematically projecting emulates imaging and so this is where 
the physics of SPECT need to be included. Including an accurate modelling of all the 
physical effects of the photon transport (i.e. attenuation, collimator/detector 
blurring and scatter) is necessary to find the original activity distribution of the 
source. The reconstruction algorithm solves the inverse problem as the unknown 
variable is the activity distribution of the source. 
 
Modelling of the PSF 
The distance dependent collimator response describes, for a given point source, the 
spatial distribution of the detected photons. Thus, the modelling of the PSF 
calculates the probability of detection of the photons through the 
collimator/detector system. PSF can be described by a Gaussian function whose 
standard deviation varies with the distance in a way that the farthest planes are 
blurred the most. The modelling of the PSF must be incorporated into the transition 
matrix to compensate for the loss of resolution. 
 
PSF has several components including geometric, scatter, and septal penetration 
components. For low-energy photons, several analytic models have been proposed 
to model PSF. These models only take into account the geometric component of the 
PSF and do not model scattering or penetration within the collimator (Metz et al 
1980, Tsui and Gullberg 1990, Frey et al 1998, Pareto et al 2002). These 
approximations are considered to be accurate enough for low-energy photons 
where the geometric component accounts for approximately 95% of the total PSF 
for both parallel and fan beam collimators (Cot et al 2002). 
 
When radionuclides which emit high-energy photons are used, such as 123I in 
neuroimaging, the non-geometric components of the PSF turn out to be non-





negligible. The decrease of the absorption cross section and the increase of the 
Compton cross section cause the geometrical component to become less relevant 
than septal penetration and scattering (Cot et al 2004). Thus, the analytical model 
for low-energy photons is not valid for high-energy emitters. PSF for 123I high-
energy photons emission has been modelled by Cot et al 2006 and is described in 
section 3.5.2. 
 
Including the modelling of the PSF in the transition matrix improves the resolution 
of the reconstructed images. 
 
Modelling of the attenuation effect 
Attenuation is described by the photon path length through the attenuating object 
from the voxel source to the projection bin and by the characteristics of the 
materials that the photon goes through, i.e. the linear attenuation coefficients of 
brain and bone in neuroimaging. The density distribution of each patient is known 
as the attenuation map. Subject specific attenuation maps can be generated from 
computed tomography (CT) scans by segmenting the different tissues, or from 
transmission data obtained with the SPECT camera and a transmission source 
(Welch et al 1997). In any case, images have to be accurately coregistered with the 
SPECT data in order to position the map correctly, which is not an easy task in some 
cases. A great advance has been achieved with hybrid SPECT/CT systems which 
simultaneously acquire SPECT and CT data, as they ensure a good attenuation 
modelling. 
 
If the attenuation map is known, the different global attenuation factors that 
correspond to each element of the transition matrix can be calculated. Thus, the 
transition matrix can be corrected for attenuation. If attenuation correction is not 
included, reconstructed images present a reduction of the signal in the centre of the 
body compared with the borders.  
 
Modelling of the scattered photons detected fraction 
There are many methodologies proposed for correcting scatter. Although for 
clinical routine only the most simple are applied, there are also much more complex 
approaches which seek to achieve ideal scatter correction. As mentioned earlier, 
the scattered fraction of the projections can be estimated using direct measurement 
or modelling (Beekman et al 1997, Kadrmas et al 1998). In both cases, estimated 





scatter can be directly subtracted from the projections prior to reconstruction, or 
incorporated into the iterative reconstruction. The latter can model scatter during 
reconstruction by including it in the transition matrix, calculating it on-the-fly, or 
estimating it separately. 
Scatter can be modelled using different approaches. One of the methodologies 
proposed is based on the calculation of the scatter response using the Klein-Nishina 
scatter equations (Riauka and Gortel 1994), but it requires long processing times 
and large data storage. Another approach is the transmission-dependent 
convolution subtraction method (TDCS) (Meikle et al 1994) originally based on the 
convolution of the photopeak counts by a mono-exponential function modelling the 
scatter response. One final method is the slab-derived scatter estimation (Frey and 
Tsui 1993, Beekman and Viergever 1995) which relies on response tables 
calculated for a source placed behind slabs of water of variable thickness. This 
method was extended with the development of effective scatter source estimation 
(ESSE) (Frey and Tsui 1996) which incorporates the attenuation from each point of 
Compton interaction to the detector. 
An alternative to these simplified models would be the use of Monte Carlo (MC) 
simulation (see section 3.5) to calculate scatter for each subject. Until recently, 
calculation times were considered wholly unpractical, especially if scatter had to be 
re-estimated at each iteration. Nowadays, methods which accelerate simulations by 
combining stochastic photon transport within the patient media with analytical 
models for detection have demonstrated that MC simulation is a feasible tool for 
scatter estimation given the distributions of activity and attenuation coefficients 
(Beekman et al 2002, Cot et al 2006). 
Methods which model the scatter distribution in the transition matrix map 
scattered photons back to their point of origin instead of trying to determine a 
separate estimation of the scatter (Kadrmas et al 1998, Lazaro et al 2005). Although 
these methods have potential benefits in terms of signal-to-noise, the inclusion of 
attenuation, collimator blurring and scatter in the transition matrix leads to 
prohibitive calculation times and memory requirements (Floyd et al 1986). As an 
alternative, measured or pre-calculated scatter can be treated as a constant term in 
the denominator of the ML-EM algorithm or can be iteratively updated during 
reconstruction. These methods use an unmatched projector/backprojector pair 
known as dual matrix implementation (Kadrmas et al 1998, Kamphuis et al 1998). 
The projection step includes attenuation, detector blurring and scatter, whereas the 





back-projection includes only attenuation and detector blurring. As a result, the 
reconstruction process is accelerated. The main advantage of adding the scatter 
term in the denominator of the algorithm is that it avoids direct subtraction, which 
negates the assumption of Poisson distributed counts in the projections and can 
result in negative values. These methods achieve their high accuracy by modelling 
scatter using MC simulations of low-noise projections, which avoids the need for 
massive transition matrix storage (Beekman et al 2002). The MC-based scatter 
correction method developed by our group is described in chapter 5. 
 
3.4 Image quantification  
Visual interpretation of the reconstructed images is, in general, suitable for clinical 
assessment. Thus, in a clinical context, diagnosis is still predominantly based on 
experienced observers’ assessment of the striatal activity. Visual assessment gives 
an idea of whether the radiotracer uptake is normal or abnormal, and may provide 
information about asymmetries and the structures most affected. Thus, the 
striatum shape, symmetry, gradient between caudate and putamen and degree of 
activity reduction is examined. However, since it depends heavily on the observer’s 
experience and shows inter- and intra-observer variability (Verhoeff et al 1993), 
current clinical guidelines recommend a quantitative analysis of the studies that 
can offer an objective assessment and improve diagnostic accuracy (Darcourt et al 
2010). 
 
Within the context of functional brain imaging, the aim of quantification is to 
provide a reliable numerical measure of the brain function (Zaidi and El Fakhri 
2008). Quantification is especially attractive in the process of early diagnosis of 
Parkinson's disease, for differential diagnosis (Koch et al 2007b), for prognosis (as 
it can help stage the patient), to strengthen diagnosis (Habraken et al 1999), 
improve sensitivity and for therapeutic management and follow-up (Seibyl et al 
1997, Booij et al 2001, Buvat 2007). In recent years, many methods which seek to 
quantify the images have been developed and quantification is still a major field of 
research in SPECT imaging. 
 
3.4.1 Absolute quantification 
The quantitative values extracted from reconstructed images are affected by the 
degradations that functional SPECT images present. All these effects need to be 





compensated for if we want quantification values that are close to the theoretical 
ones. In order to recover the true values that correspond to the real distribution of 
the radionuclide in the patient’s brain, absolute quantification is needed. Absolute 
quantification is only dependent on the patient’s brain function. 
 
As mentioned above, the development of accurate corrections for degradations is 
still a highly active field of research on the path to absolute quantification. In 
chapter 5 the full methodology developed by our group for the absolute 
quantification of SPECT studies of the dopaminergic system is explained in detail. 
Nevertheless, although methodologies based on the correction of all degradations 
for each subject are accurate, realistic and instructive, the need for additional CT 
images to generate individual attenuation maps and magnetic resonance (MR) 
images to create subject specific maps of the regions of interest (ROI), calculation 
times and storage data requirements still make it prohibitive to transfer these 
methods into clinical routine. So, for the time being, they are applied only for 
academic purposes and research trials, where these practical limitations are not so 
crucial. 
 
3.4.2 Semi-quantitative evaluation 
At present, quantification mainly relies on semi-quantification methods. These 
methods use dedicated software to elicit numerical information from the 
reconstructed images to quantify radiopharmaceutical uptake in the regions of 
interest, i.e. caudate and putamen, with respect to reference areas. Convenient 
semi-quantitative parameters to measure are the specific uptake ratio (SUR) or the 
specific binding ratio (SBR). Both ratios are a measure of the mean counts in the 
ROIs defined in the striatum with respect to the mean counts in ROIs defined in 
areas which are devoid of nigrostriatal neurons, such as the occipital lobe. 
Determination of derived indexes such as putamen to caudate ratios, left and right 
asymmetries, etc. are also helpful when interpreting results. 
 
Although visual assessment is still the basis of image interpretation, semi-
quantitative evaluation is recommended in clinical protocols. However, there is no 
common methodology either in the definition of the ROIs or in the indexes chosen 
to evaluate the images, and its implementation varies from centre to centre. This 
means that many semi-quantitative methods have been developed to assist 
diagnosis. The main differences between them lie in the procedure chosen to draw 
and locate the ROIs on the image. This procedure can vary from manual drawing 





methods to automated techniques based on normalisation, registration, fusion and 
segmentation (Badiavas et al 2011). While manual positional methods are more 
usually found in clinical routine, advanced automated and semi-automated 
quantification methods are already being used in research trials. 
 
Anatomical ROIs based on MRIs 
A recent magnetic resonance imaging (MRI) scan of the patient can be used to draw 
the patient’s striatum structures and define precise anatomical ROIs. In this 
technique, the segmentation of the structures can be drawn manually or solved 
using specific software such as FSL (FMRIB, University of Oxford, UK) (Patenaude et 
al 2011). In order to place the ROIs ready for quantification, the ROIs map and the 
MRI scan need to be coregistered with the SPECT image. The use of external 
markers attached to the patient’s head increase the accuracy of SPECT-MR 
registration (Seibyl et al 1995, van der Wee et al 2008). ROIs obtained by this 
method can be considered a gold standard as they are based on the individual 
morphology of each patient. 
 
The technique is particularly useful when a region presents a very low uptake 
poorly contrasted on the functional image. Unfortunately, this methodology is 
difficult to adopt in clinical routine as MRI scans are not usually included in the 
diagnostic procedures for PD and schizophrenia. In addition, the delineation of 
ROIs is a time-consuming task that requires skilled professionals and the use of 
dedicated software. Consequently, although accuracy is reduced, it is more common 




To reduce operator intervention, current clinical guidelines recommend that 
functional images are normalised to a standard space before quantification. The 
main advantage of incorporating a normalisation step into the quantification 
procedure is that it allows a unique template of ROIs to be defined in a standard 
space. This standard template can then be used to quantify all the normalised 
studies, simplifying and speeding up the quantification process. The application of 
this template of ROIs can be done directly or with the final intervention of the 
operator or some software that adjusts the ROIs to each study. Normalisation 
modifies the anatomy of the study so that it matches the template whilst preserving 





the activity distribution of the brain structures. So semi-quantification results are 
not modified by this technique. 
 
Specially-designed software packages for the analysis of brain imaging data such as 
SPM (Statistical Parametric Mapping; Wellcome Trust Centre for Neuroimaging) 
come with standard templates for several modalities of anatomical and functional 
imaging. Templates are usually defined in the MNI standard space, which was 
defined by the Montreal Neurologic Institute. Automated Anatomical Labelling 
(AAL) is a standardised anatomical ROI map defined in the MNI standard space that 
provides generic templates for all brain structures (Tzourio-Mazoyer et al 2002). 
 
Nevertheless, some institutions and research centres choose to create their own 
templates using scans of their own control subjects. This procedure requires a MR 
image and a SPECT study of each normal control. The creation of the template 
starts with the coregistration of the MR and SPECT images. Then, the coregistered 
images are normalised to a standard space, usually the one defined by MNI. 
Generally, MR images are normalised to the T1-weighted template and the same 
transformations are applied to the SPECT images. Finally, the normalised images 
from the same technique (MRI and SPECT, separately) are summed together and 
averaged out. The result is usually smoothed by the application of a Gaussian filter. 
Home-made MRI and SPECT templates can then be used to define the template of 
ROIs. 
 
Advanced semi-quantification methods usually incorporate a registration algorithm 
to normalise the studies to the standard space before applying the predefined 
template of ROIs. The template of ROIs can be based on anatomical maps (such as 
the AAL map) or may consist of a predefined location of geometrical ROIs 
(frequently circular) in a few consecutive transaxial slices. Slices may be selected 
visually as representing the most active areas of the striatum or by identifying the 
slice with maximum counts and adding a number of slices either side of it. There is 
no width considered as globally standard and typical values used by institutions 
can vary from around 10 to 30 mm (Walker et al 2002, Varrone et al 2004). 
 
The main drawback of these techniques lies in the limitations inherent in the 
normalisation process. The application of a 3D pre-filtering to the studies is 
recommended in order to smooth the images and facilitate normalisation. However, 
some studies may require additional programming to ensure accurate 
normalisation, such as those with low uptake ratios, or where anatomically pre-





defined ROIs such as the AAL map are used. Anatomical differences between 
predefined anatomical ROIs and the real structures can cause inaccurate 
quantifications. In spite of the complexity of this technique, normalisation of studies 
to a standard space before applying the template of ROIs is becoming mandatory in 
leading centres. 
 
Problems derived from semi-quantification: need of standardisation 
In clinical routine, the interpretation of the quantitative information elicited from 
the image is based on its comparison with those values obtained with age-matched 
normal controls. The main advantage of using relative quantification is that there is 
no need to correct for those effects that will in the main be cancelled out in the 
comparison. However, this only occurs when the same type of scanner, acquisition 
protocol, reconstruction parameters and quantification procedure are used to 
obtain the values of the reference normal database. Thus, those reference values 
are not standard and cannot be transferred to other centres. 
 
As mentioned above, results provided by semi-quantification methods are 
dependent on the imaging system and acquisition protocol, the corrections applied 
for the degrading phenomena and the quantification procedure (size and 
morphology of the ROIs, selected slices, location of the ROIs, image registration, 
etc.). This dependence is of enormous importance since it prevents the creation of a 
single unambiguous standardised database that would help differentiate between 
known diseases and their states. The lack of a single standard database forces 
nuclear medicine centres to create their own local normal databases. But to obtain 
standardised values, somehow all the degrading effects need to be compensated for 
in order to recover the true ratios corresponding to the original activity 
distribution in the patient (El Fakhri et al 2001, Soret et al 2003). 
 
As an alternative to the arduous task of correcting all the degrading effects study by 
study (as is done in absolute quantification), standardised values may be obtained 
if a direct relationship between the calculated results and the real values could be 
established. To calculate the standardising function, anthropomorphic brain 
phantoms could be used since the true activity distributions are known. To make 
this standardisation possible, the anthropomorphic phantom should follow the 
same nuclear imaging protocol as patients and should be shown to be 
representative of the average anatomy of the population. The main drawback of 
this technique is the fact that calculated values would be standardised according to 





a function defined for the particular anatomy of the phantom. Thus, significant 
errors could occur in those patients with large anatomical differences with respect 
to the phantom. 
 
3.5 Monte Carlo simulation in SPECT 
Monte Carlo (MC) simulation is a statistical simulation method based on random 
numbers generated according to the dynamics of the system under study. MC 
simulation is applied to those problems which can be globally described by 
probability density functions. The physics of radiation emission, transport and 
detection makes MC simulation the appropriate tool for modelling SPECT imaging 
and other nuclear medicine techniques (Zaidi 1999, Buvat and Castiglioni 2002, 
Rogers 2006, Buvat and Lazaro 2006).  
 
MC simulation in emission tomography is applied to the design and selection of 
gamma cameras and their components (Lupton and Keller 1983, Bradshaw et al 
1985); modelling of the detector system response (PSF) (Du et al 2002, Cot et al 
2004, Staelens et al 2007); modelling of the spatial and energy distribution of 
Compton scatter (Cot et al 2002; Zaidi and Koral 2004); the study of the effect and 
contribution of each image degradation (Crespo et al 2008); the design and 
assessment of image-degrading compensation methods (Ljungberg and Strand 
1990) and the design and evaluation of quantification protocols (Cot et al 2005). 
Since the original activity distribution of the source is known, MC simulation 
permits the testing of semi-quantification methodologies using a variety of 
anatomical and tracer uptake cases that would be almost impossible to reproduce 
otherwise. Thus, MC simulations allow the reliability of applied methodologies to 
be confirmed and identify any inherent errors in the method used. 
 
3.5.1 Monte Carlo codes for emission tomography 
Depending on the specificity of its application, MC codes for particle transport are 
classified into general purpose codes and dedicated codes. General purpose codes 
are more flexible and, in general, provide more detailed simulations. On the other 
hand, dedicated codes for SPECT focus on the relevant aspects for the emission 
tomography omitting those which are not relevant for the application. As a result, 
they are often faster and easier to program by the user. 
  





General purpose codes available for nuclear medical applications are: EGS4 
(Murray 1990), MCNP (MCNP directory), PENELOPE (PENELOPE home page), ITS 
(Halbleib et al 1992) and GEANT (GEANT4 home page). Dedicated MC packages for 
SPECT are: SIMIND (Ljungberg and Strand 1989), SimSPECT (Belanger et al 1998) 
and MCMATV (Smith et al 1993). Among the most frequently used codes for both 
SPECT and PET simulations are GATE (Yanch et al 1992) and SimSET (Haynor et al 
1991). Basically, these codes differ on the energy range of the simulated particles, 
the physical models and approximations applied to describe interactions, the 
geometric limitations in the definition of the bodies and sources, and the interface 
with the user.  
 
In this doctoral dissertation, SimSET was used to simulate SPECT projections after 
introducing some improvements into the code. 
 
3.5.2 SimSET 
Simulation System for Emission Tomography (SimSET) is a dedicated MC code for 
the simulation of the physical processes and the instrumentation used in SPECT 
and PET. SimSET was developed in 1993 at the Imaging Research Laboratory at the 
University of Washington for public distribution to Nuclear Medicine research 
centres and it runs on a wide range of computer platforms. It is a fast code that 
considers the specific parameters of a SPECT acquisition, such as the number of 
projections, the number of counts, the radius of rotation, the field of view, the 
energy window and the pixel size among other variables. 
 
The code must be provided with an image of the distribution of the radiation source 
(activity map) as well as of the tissues or materials that surround it (attenuation 
map). In order to characterise the collimator, the description of its main features 
must be specified: septal thickness, hole size and focal distance for fan-beam 
collimators. One interesting point is that this code allows discrimination of the 
different components of the resulting projections into scattered and unscattered 
photons. In addition, it allows the introduction of some modifications to the code so 
as to improve it. 
 
Like other dedicated MC simulators, SimSET uses analytical functions to accelerate 
the tracking process through the collimator/detector system. The task would 
otherwise require intensive computational processes that make it impossible to 
complete in a reasonable time using current computers. These analytical functions 





calculate the probability of detection through the collimator/detector system for 
each photon and are based on PSF responses. 
 
PSF model for low-energy photons 
The collimator response originally implemented in SimSET was based on a PSF 
model developed for low-energy photons (Metz et al 1980, Tsui and Gullberg 1990, 
Frey et al 1998) which only took into account the geometric component of the PSF. 
As this model presents some inaccurate hypotheses (see Cot 2003 for a detailed 
analysis), our group decided to develop a new PSF model after a MC study. 
 
In Cot et al 2002, a complete characterization of a fan-beam collimator response to 
99mTc point sources was carried out using the MC code PENELOPE (PENELOPE 
home page). MC simulation was performed using a detailed representation of the 
hexagonal shape of the holes of the collimator as well as its pattern. All the 
collimator effects were carefully simulated. In order to differentiate contributions 
to the final PSF, each photon reaching the detector layer was flagged according to 
its past interactions as either geometric photons (no interaction suffered and no 
septa crossed), septal penetration (no interaction, one or more septa crossed), 
photons that underwent deflection due to a coherent interaction without energy 
loss (Rayleigh) or photons that underwent deflection due to an incoherent 
interaction with energy loss (Compton). Detector effects were not included in the 
simulations. Figure 3.9 shows the four components of the PSF for a 99mTc point 
source. 
 
As a result of this study, it was found that the major contribution to the fan-beam 
PSF was the geometric component, i.e. the geometric pattern of the holes of the 
collimator, which represented approximately 95.1% of the total PSF. Septal 
penetration was the second major contribution with 3.7%. Rayleigh photons had a 
contribution of 1.1% and the Compton interaction was 0.1%. These results were in 
accordance with those obtained by De Vries (De Vries et al 1990) with a parallel 
collimator. Thus, a complete collimator/detector response could be obtained by 
convolving only the geometrical PSF with the intrinsic response of the detector. The 
result was fitted to a Gaussian function with a high correlation coefficient. 
 
This work demonstrated that ray-tracing techniques that allow calculating the 
geometrical component of the PSF are good enough to model the PSF for low-
energy photons (Pareto et al 2002). 






Figure 3.9 PSF components for a 
99m
Tc point source located at 10 cm from the collimator front 
plane: geometric component (top left), septal penetration (top right), coherent scatter (bottom 
left) and incoherent scatter (bottom right).  
 
Thus, our group replaced the original PSF model of SimSET (Frey et al 1998) with a 
more accurate PSF model developed in-house using ray-tracing techniques (Pareto 
et al 2002). In this model the sensibility of the collimator, i.e. the amplitude of the 
Gaussian function, was modelled as: 
 





Where 𝐹 is the focal length, 𝐿 is the thickness of the collimator and 𝑍𝑠  is the 
distance between the source and the collimator. 𝜃 is the source aperture angle, 
which is the angle between the normal to the collimator and the straight line that 
joins the source point and its interaction point with the detector. 𝑘-constants are 
parameters that have to be fitted to experimental or simulated data. 
 
The resolution, i.e. the standard deviation of the Gaussian function, on the x-axis, 
which is the direction in which the fan-beam collimator amplifies the image, was 
modelled as: 
 























Where 𝐵 is the distance between the back collimator face and the image plane and  
𝑅 is the distance between the centre and the vertex of the hole. 
 
The parallel collimator is a particular case of the fan beam collimator where the 
focal distance is infinite. 
 
The intrinsic resolution of the detector is known to follow a Gaussian distribution. 
The standard deviation of this distribution can be obtained from experimental 
measurements and convolved with the collimator response. 
 
Given the similar behaviour between the low-energy line from 123I and photons 
emitted by 99mTc, the PSF model for low-energy photons is also suitable for 123I low-
energy emission. 
 
PSF model for high-energy photons 
The photon emission of 123I is dominated by a low-energy line of 159 keV (97%) but 
it also emits several high-energy lines at 248 (0.08%), 281 (0.09%), 346 (0.15%), 
440 (0.50%), 505 (0.37%), 529 (1.62%), 538 (0.44%), 624 (0.10%) and 783 
(0.07%). Please note that only those rays with a yield larger than 0.06% have been 
listed. Low and high-energy photons generate very different responses in the 
gamma camera that need to be modelled separately. 
 
As it has been previously shown, the deterministic modelling of the PSF is accurate 
enough at low-energy ranges. At higher energies, the non-geometric effects turn out 
to be non-negligible and thus, the geometrical model is no longer valid. All the 
interactions that take place at the backscatter compartment of the detector (optical 
guide, photomultipliers, electronics, electric wires, shielding materials, etc.) cause 
high-energy photons emitted by 123I to lose part of their energy and make a non-
negligible contribution to the projections. For the highest yields emitted, i.e. 440, 
505, 529 and 538 keV, the backscatter peaks are 162, 170, 172 and 173 keV, 
respectively. Thus, they all fall within the detection window centred on 159 keV 
(Dobbeleir et al 1999, Cot et al 2004, Staelens et al 2007). 
 





Taking a similar approach to that developed by Cot et al 2002 for the study of the 
PSF for low-energy photons, in Cot et al 2006 our group used PENELOPE to 
simulate the high-energy lines of 123I with yields higher than 0.1%, i.e. 346, 440, 
505, 529 and 538 keV. High-energy lines were simulated as isotropic sources 
located at different distances from a LEHR fan-beam collimator and at different off-
axis positions. Since the collimator geometry was formed by approximately 40.000 
hexagonal holes, the simulation was simplified by considering one single hole 
whose position and geometry varied on the fly, according to the location of the 
photon tracked. The backscatter compartment was simulated as a single layer of 
Pyrex since the characteristics of the backscatter phenomena were found to be 
better reproduced using this material than others such as iron or copper (De Vries 
et al 1990, Cot et al 2004). The thickness of the layer was selected to match with the 
sensibility of the experimental measurements. MC simulations were validated 
against experimental measurements using 18F-FDG point sources emitting photons 
of 511 keV. 
 
Results showed that PSF for high-energy photons extends over the whole field of 
view (FOV) and it can be modelled using the following Gaussian function: 
 










      (3.8) 
 
where 𝑥 and 𝑦 are Cartesian coordinates on the collimator front plane and the 
parameters 𝐴, 𝑏𝑥  and 𝑏𝑦  depend on the energy and location of the source  𝑥0 , 𝑦0 . 
 
Probability density functions (PDF) were generated by our group to characterize 
the following gamma cameras: Elscint HELIX equipped with a LEHR fan-beam 
collimator (Cot et al 2006), Siemens E.CAM with a LEHR parallel-hole collimator 
(Crespo et al 2008), and Picker PRISM 3000 S with a LEHR fan-beam collimator 
(Roé 2011). PDF describes the response of the collimator/detector system and is 
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SPECT images allow the study of the dopaminergic system using 
radiopharmaceuticals labelled with 123I. As mentioned in chapter 3, the original 
SimSET MC code included a PSF model that was valid for low-energy photons but 
not appropriate for the high-energy photons emitted by 123I with energies above 
200 keV. The contribution of the high-energy photons to the projections comes 
from the scattering and penetration effects that high-energy photons undergo 
within the collimator and, especially, in the backscatter compartment of the 
detector (Cot et al 2004, Rault et al 2011), which causes them to lose part of their 
energy and thus fall within the energy window. As this can result in inaccurate 
simulations (De Vries et al 1990, Dewaraja et al 2001) which are unacceptable for 
most applications, our group developed a PSF model for the high-energy emission 
of 123I after a detailed MC simulation study (Cot et al 2006). 
 
Once the PSF model for high-energy emission had been defined, PDF functions for 
different collimator configurations were generated by our group and incorporated 
into the collimator module of SimSET. PDF functions are dependent on the energy 
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and on the location of the source. With the inclusion of these functions, the new 
version of SimSET calculates “on the fly” the probability of detection at the bin hit 
by the photon. This probability is calculated as the integral of the PDF over the 
projection bin. PDF is considered to be centred at the intersection of the backplane 
of the collimator with the perpendicular line from the point of the last interaction of 
the photon to the focal line. The probability of detection is calculated for all 
available collimator views. This methodology speeds up the simulation with respect 
to other approaches such as those based on angular response functions (ARF) 
(Song et al 2005). ARF functions are dependent on the energy and the direction of 
the incident photon. They store the probability that the incident photon passes 
through the collimator and is detected within the energy range, at the intersection 
point of the photon direction vector and the detection plane. These functions are 









This chapter covers the experimental validation of the new version of SimSET for 
the simulation of 123I SPECT studies using a Picker PRISM 3000 S equipped with a 
LEHR fan-beam collimator. Validation was performed by comparing the 
experimental projections obtained from an anthropomorphic striatal phantom 
using the Picker PRISM system and the simulated projections obtained from a 
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of SimSET. This version included the PDF functions previously obtained for this 
collimator/detector system. The scheme of the approach is shown in figure 4.1 and 
developed in the following sections. 
 
4.2 Materials and methods 
4.2.1 Experimental projections 
Striatal brain phantom 
The anthropomorphic striatal brain phantom (Radiology Support Devices, RSD. Inc, 
Long Beach, CA) was used to mimic real SPECT studies with 123I-labelled 
pharmaceuticals (see figure 4.2). 
 
This phantom consists of five compartments which correspond to the left and right 
caudate nuclei and putamen, and the rest of the brain. All these structures have a 
normal human brain shape and size, and are surrounded by two different materials 
which are equivalent to soft tissue and bone. 
 
  
Figure 4.2 The anthropomorphic striatal brain phantom. 
 
Data acquisition 
Experimental projections of the striatal brain phantom were acquired using a 
Picker PRISM 3000 S gamma camera equipped with a LEHR fan-beam collimator 
(see figure 4.3). The main parameters of the imaging system are summarised in 
table 4.1. 
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The four compartments of the striatum of the phantom were filled with the same 
activity concentration. Radiotracer distributions corresponding to SUR values of 
0.00, 1.97, 3.73 and 6.63 were considered so as to cover a range of normal and 
pathological distributions. 120 projections over 360° with a 20% energy window 
centred on 159 keV (143-175 keV) were acquired. A 128x128 matrix with a bin size 
of 3.55 mm was selected. The radius of rotation was set to 14.5 cm. All 
experimental studies were set to have more than 2.5 million counts. To statistically 
assess the influence of noise, acquisitions were repeated consecutively six times for 
each SUR value. Finally, the set of studies corresponding to each SUR value were 
normalised to the number of counts of the first acquisition. 
 
 
Figure 4.3 Acquisition of the experimental projections of the striatal brain phantom with the 
Picker Prism 3000 S gamma camera. 
 
Table 4.1 Parameters of the PRISM SPECT system 
Parameter PRISM SPECT system 
Collimator LEHR fan-beam 
Focal length (mm) 650 
Hole shape Hexagonal 
Hole radius (mm) 0.86 
Septal thickness (mm) 0.15 
Length (mm) 27.00 
Crystal thickness (mm) 9.50 
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4.2.2 Simulated projections 
The modified SimSET simulator 
Simulated projections were generated using the new version of the SimSET code. In 
this version, SimSET was modified by the inclusion of the high-energy PDF 
functions calculated for the Picker imaging system. These functions allow 
acceleration of the MC simulation by calculating the probability of detection 
through the collimator/detector system for each photon. 
 
The adjustments of the PDF functions for the high-energy emission of 123I were 
incorporated into the collimator module of SimSET in the form of look up tables. 
These tables were previously calculated using the MC code PENELOPE and then 
included in SimSET. 
 
Look up tables are dependent on the collimator/detector configuration and on the 
isotope, and contain the values of the parameters  𝐴, 𝑏𝑥  and 𝑏𝑦  from equation (3.8). 
Since these parameters are dependent on the energy and on the location of the 
source  𝑥0 , 𝑦0  a selected number of energies and locations were considered. In 
particular, values were calculated for the energy lines with yields higher than 0.1%, 
i.e. 346, 440, 505, 529 and 538 keV, located at 5, 10, 15, 20 and 25 cm from the 
collimator front plane. When the simulated photon in SimSET does not have any of 
the energies considered and/or it is not located at any of the positions considered, 
the parameters 𝐴, 𝑏𝑥  and 𝑏𝑦  are calculated by applying an interpolation of energies 
and/or locations. PDF look up tables were incorporated into the new version of 
SimSET together with the geometric PSF model developed for low-energy photons. 
 
SPECT projections were simulated using a simplified emission model which 
considers that all the high-energy lines from 123I are equivalent to one single line of 
529 keV with a yield of 3% (Roé 2011). 
 
Numerical phantom 
A computed tomography (CT) scan of the anthropomorphic striatal brain phantom 
was acquired to create the numerical phantom for the simulation. The CT image 
had 256x256x196 voxels, with a voxel size of 0.89x0.89x0.89 mm3. The attenuation 
map was generated by segmenting the CT image into brain tissue and bone using an 
intensity threshold. The activity map was defined by manually drawing the striatal 
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cavities over the corresponding slices. Maps were selected to have 80x80x64 
voxels, 3.56x3.56x3.56 mm3. In order to guarantee the same orientation as in the 
experimental study, the attenuation and activity maps were coregistered with the 
experimental studies reconstructed with FBP. 
 
MC simulation of the projections 
Simulated projections were generated using the modified SimSET code with the 
same parameters as those used for the experimental acquisitions. The simplified 
123I emission model was applied, i.e. 97% of photons with 159 keV and 3% of 
photons with 529 keV. Since the linear attenuation coefficients are dependent on 
the energy of the simulated photons, the coefficients of the attenuation map were 
different for the simulation of low and high-energy emissions. 
 
A very high signal-to-noise ratio simulation was carried out for each experimental 
SUR value. To this end, MC simulation was performed to obtain a variance one 
hundred times lower than the total counts in projections. Thus, these projections 
could be considered to be noise-free. Each study took approximately 3 hours in a 
processor with 3.2 GHz clock speed. Finally, counts obtained in the simulated 
projections were compared with the mean counts of the six consecutive 
experimental projections. 
 
4.3 Results and discussion 
Figures 4.4 and 4.5 show the experimental and simulated profiles for a set of 
several representative projections (front, lateral left, back and lateral right 
projections) and for two of the considered SUR values. Figures 4.6 and 4.7 show the 
corresponding profiles of one selected row of the aforementioned projections. The 
row was selected to include the striatal nuclei. Experimental results are 
represented by the mean value found for the six acquisitions made and by the error 
bar corresponding to one standard deviation. The simulated profiles are 
represented by the value found for each projection bin. Similar profiles were 
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Figure 4.4 Experimental (black circles) and simulated (white circles) profiles of projections of the 
striatal phantom for a SUR value of 0. Experimental values are represented as the average value 
of the six acquisitions and by the error bar corresponding to one standard deviation. 
 
 
Results show that the simulated curve follows the experimental within the error 
interval for almost all projections. This behaviour is also observed in the results 
corresponding to the row that contains information of the striatum. 
 
Differences found for those projections that correspond to the view of the back of 
the phantom can be explained by the attenuation caused by the head-holder. Since 
the simulation does not include this device, experimental and simulated profiles 
diverge in those projections that are most affected by the head-holder for all SUR 
values. So, when part of the head-holder is located between the phantom and the 
detector, the simulated profile would be above the experimental values. 
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             Front projection           Lateral left projection 
 
 
           Back projection                        Lateral right projection 
 
 
Figure 4.5 Experimental (black circles) and simulated (white circles) profiles of projections of the 
striatal phantom for a SUR value of 6.63. Experimental values are represented as the average 
value of the six acquisitions and by the error bar corresponding to one standard deviation. 
 
 
In order to compare the projections quantitatively, the root mean square deviation 
(RMSD) was used to estimate the difference between simulated and experimental 
pairs of images. This parameter is defined as follows: 
 
𝑅𝑀𝑆𝐷 =  
1
𝑁
  𝑆𝑖 − 𝑂𝑖 
2𝑁
𝑖=1  (4.1) 
 





Profiles of the front view projection of the phantom 
Projection bin














Profiles of the back view projection of the phantom 
Projection bin













Profiles of the lateral view projection of the phantom 
Projection bin














Profiles of a lateral view projection of the phantom 
Projection bin














Chapter 4: Validation of SimSET for 
123






RMSD values found for each considered SUR are shown in table 4.2. These values 
indicate the mean deviation in the number of counts in each bin between 
experimental and simulated projections.  
 





















            












Figure 4.6 Experimental (black circles) and simulated (white circles) profiles corresponding to one 
row of the projection for a SUR value of 0. Experimental values are represented as the average 
value of the six acquisitions and by the error bar corresponding to one standard deviation. 
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Figure 4.7 Experimental (black circles) and simulated (white circles) profiles corresponding to one 
row of the projection for a SUR value of 6.63. Experimental values are represented as the average 
value of the six acquisitions and by the error bar corresponding to one standard deviation. 
 
 
As it can be observed, the calculated RMSD values for all SURs are remarkably 
similar, all falling in the range of 1.3-1.5. These values indicate that the differences 
between simulated and experimental projections are negligible. In fact, these 
differences are lower than those found between two experimental acquisitions 
corresponding to the same SUR. It should be remembered that the experimental 
acquisitions for each SUR value were performed successively, without modifying 
any parameter of the imaging system. Thus, experimental acquisitions were 
essentially not affected by any additional noise other than statistical noise. In 
addition, comparison is performed between the mean value of the six consecutive 
experimental acquisitions (once normalised to the number of counts of the first 
study) and the profile given by the very high signal-to-noise ratio simulation. Thus, 
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the effect of noise in this comparison is certainly low so as to ensure that RMSD 
values are primarily a result of the simulation model applied.  
  
4.4 Conclusions 
This work confirms that the PDF functions incorporated into the collimator module 
of SimSET, make this code a reliable and accurate tool for the simulation of SPECT 
studies of the dopaminergic system using 123I. 
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5 Absolute quantification 
 of dopaminergic 
 neurotransmission 
 SPECT studies with 123I 
 for research trials 
 
5.1 Introduction 
Several methodologies have been proposed to correct the non-desirable effects that 
degrade SPECT images and impair accurate quantification such as attenuation and 
PSF (El Fakhri et al 2001, Pareto et al 2003), scatter (Hutton et al 2011) and the 
partial volume effect (PVE) (Soret et al 2003). In 2005, our group at Hospital Clínic 
of Barcelona (Barcelona, Spain) developed a complete method named Absolute 
Quantification Method (AQM) for the accurate quantification of dopaminergic 
neurotransmission SPECT studies obtained using 99mTc-labelled radioligands (Cot 
et al 2005). This method performed a fully 3D iterative reconstruction with 
attenuation and PSF corrections and included a MC-based scatter compensation. 
 
Since SPECT imaging makes most use of 123I-labelled radioligands, an extension of 
the previous AQM was needed to adapt this method to the particularities of 123I 
photon emission. As previously seen in chapter 3, in 123I SPECT imaging, the 
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contribution from high-energy photons (above 200 keV) is not negligible, because 
the backscatter peaks of these emission lines fall well inside the detection window 
(Cot et al 2004, Du et al 2006). This so called high-energy contamination needs 
careful attention because, while in the decay scheme of this radioisotope the high-
energy yield is low (~3%), its contribution to the total counts in the projections 
may be important. So AQM was modified to include a MC-based scatter 
compensation for the effect of the high-energy photons in 123I SPECT studies. Given 
its significance, the method was also provided with a handy post-reconstruction 
compensation for PVE. 
 
 
Figure 5.1 Scheme of the methodology applied to validate AQM for 
123
I SPECT studies. 
 
The new version of AQM was tested using two different imaging systems equipped 
with a parallel and a fan-beam collimator, given that both types of collimator are 
regularly used in 123I neurotransmission SPECT imaging (Darcourt et al 2010, van 
Laere et al 2010). 
 
The new version of the SimSET MC code was used to generate the projections. Thus, 
quantitative results could be compared with the true values to evaluate their 
reliability and accuracy. Ideally, quantitative values provided by AQM should be 
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projections. Moreover, quantitative values should be similar for both imaging 
configurations after correcting for all degradations. The scheme of this approach is 
shown in figure 5.1. 
 
5.2 Materials and methods 
5.2.1 Numerical phantom 
Simulated projections were generated by using the numerical phantom obtained 
from a CT scan of the anthropomorphic striatal brain phantom shown in figure 4.2. 
The CT scan consisted of 256×256×196 cubic voxels with a voxel size of 
0.89×0.89×0.89 mm3. Brain tissue and bone were automatically segmented by 
thresholding the CT image, while the striatal cavities were manually drawn over the 
corresponding slices. 
 
The attenuation map was obtained by setting the appropriate attenuation 
coefficients to brain and bone. The value of these coefficients was changed 
according to the energy of the simulated photons, i.e. low and high-energy 
emissions. Thirty different activity distributions were considered with SUR values 
which modelled normal and pathological distributions of 123I-FP-CIT. The striatum 
was considered to have uniform activity distribution and tracer uptake was 
considered to be the same in caudate and putamen. Figure 5.2 shows a central slice 
of the activity and the attenuation maps used in the simulations. 
 
 
Figure 5.2 A central slice of the activity (left) and attenuation (right) maps derived from the 
anthropomorphic striatal brain phantom. 
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5.2.2 Simulated projections 
The new version of the SimSET MC code for the simulation of 123I SPECT studies 
(see chapter 4) was used to simulate the projections of the following two imaging 
systems: Siemens E.CAM with LEHR parallel-hole collimator and Elscint HELIX with 
LEHR fan-beam collimator. Low-energy photons with 159 keV and a yield of 97% 
and high-energy gamma-rays with 529 keV and a yield of 3% were simulated 
separately, following the simplified emission model shown in chapter 4. Finally, the 
generated projections for the low and high-energy emissions were added together 
to obtain the total projections. 
 
Table 5.1 summarises the simulation parameters used for both imaging systems. 
The differences in the setting that can be observed are due to the different 
acquisition protocols used for each gamma camera. Energy windows were selected 
according to the values proposed by the manufacturers. 
 
Table 5.1 Simulation parameters used with each SPECT system. 
Parameter E.CAM system HELIX system 
Collimator LEHR parallel-hole LEHR fan-beam 
Focal length (mm) NA 355 
Hole shape Hexagonal Hexagonal 
Hole radius (mm) 0.641 0.866 
Septal thickness (mm) 0.16 0.20 
Length (mm) 24.05 40.00 
Number of projections 128 120 
Matrix size 128×128 128×128 
Bin size (mm) 3.900 4.424 
Energy window (%) 15 20 
Radius (mm) 150 150 
 
A total of 30 real-noise projections for each SPECT gamma camera were generated 
by employing the randomly distributed values of SUR ranging from 0.1 to 6. All the 
simulated studies were considered to have approximately 3 million counts, thus 
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5.2.3 Reconstruction algorithm  
AQM for 123I SPECT 
AQM is an iterative reconstruction algorithm based on OSEM which performs a fully 
3D-reconstruction with attenuation and PSF corrections and includes a MC-based 
scatter compensation. In AQM, the voxel values 𝜆𝑖  of the reconstructed image are 















𝑗=1  (5.1) 
 
Where 𝜆𝑖
𝑘  is the image estimation at iteration k; 𝑡𝑗𝑖  represents the transition matrix; 
𝑝𝑗  represents the original projections;  𝑡𝑗𝑚 · 𝜆𝑚
𝑘  𝑚 is the projection bin j after 
forward projection of the image estimation at iteration k; and 𝑆𝑗  is the scatter 
contribution estimated in bin j. 
 
Thus, the estimated scatter distribution is used in the denominator of the OSEM 
algorithm as a constant additive term in the forward projector equation (Bowsher 
and Floyd 1991). The transition matrix incorporates the modelling of attenuation 
and the geometric component of the PSF for low-energy emission which can, 
therefore, be corrected in the back-projection. 
 




𝐻𝐸  (5.2) 
 
Where 𝑆𝑗
𝐿𝐸  and 𝑆𝑗
𝐻𝐸  are the low and high-energy photons which have undergone 
scattering and have been finally detected. 
 
Figure 5.3 shows the scheme of the reconstruction algorithm. Firstly, the original 
projections are reconstructed without scatter compensation (𝑆𝑗 = 0) at loop 0. 
Then, the reconstructed image at loop 0 is used as the input activity map of the 
SimSET MC simulator to estimate the scatter distribution. The image at the first 
iteration is the one selected as the input activity distribution of the SimSET 
simulator. Photon emission is weighted according to the emission yields of the low 
(97%) and high-energy photons (3%), which are simulated separately. 
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SimSET simulates scatter phenomena in the object but to accelerate the process, 
scatter in the collimator/detector system is modelled using the analytical models 
based on the low and high-energy PSF described in chapter 3. The scatter estimate 
is generated only once. A high signal-to-noise ratio scatter distribution is estimated 
to facilitate convergence (Beekman et al 1997). Once calculated, the scatter 
distribution is included in equation (5.1). As the scatter fraction is included in the 
forward projector, scatter correction does not remove counts from the original 
projections and so noise is not increased after scatter correction. 
 
 
Figure 5.3 Scheme of the AQM method. 
 
Reconstruction of the simulated projections 
Table 5.2 summarises the reconstruction parameters used for each imaging system. 
Given that the convergence of the reconstruction process is not the same for the 
two SPECT systems, the number of iterations needed for each camera was different. 
An additional iteration was calculated whenever the recovered SUR values 
increased at least by 1%. Projections had to be filtered with masks before 
reconstruction because of high-energy contamination. Thus, the values located 
outside the field of view of the phantom were discarded to prevent them from 
interfering in the reconstruction process. Masking was performed by applying a 
geometric projector to the attenuation map and giving a value of 1 inside the 
resulting projections and 0 outside their limits. 
Original 123I SPECT 
projections
Estimated scatter for 





attenuation, PSF and 
scatter corrections
Reconstructed 
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Table 5.2 Reconstruction parameters used with each SPECT system. 
Parameter E.CAM system HELIX system 
Pixel size (mm) 2.296 2.296 
Slice thickness (mm) 3.900 4.424 
Image size 128×128 128×128 
Number of slices 45 40 
Number of subsets 32 30 
Number of iterations 8 6 
Reconstruction time per study (h) 2 2 
 
5.2.4 Quantification with PVE compensation 
The partial volume effect 
As seen in chapter 3, accurate quantification in SPECT is impaired, inter alia, by the 
different non-desirable effects that affect acquisition, degrading the contrast and 
resolution of the SPECT images. In addition to these phenomena, reconstructed 
images present the so called partial volume effect (PVE). 
 
PVE manifests as an underestimation of the activity in small high-activity 
structures, such as caudate and putamen, due to the finite spatial resolution of the 
SPECT technique. PVE causes part of the activity from a certain structure to spill 
over to adjacent regions, distorting the true activity distribution in all regions. PVE 
is a major source of bias in SPECT neuroimaging (Soret et al 2007) and it may be 
boosted during the quantification process as a result of segmentation, 
coregistration and normalisation processes. 
 
Due to the strong influence of PVE on the quantitative results, a number of PVE 
correction methods have been developed in parallel by different research groups 
(Rousset et al 1998, Frouin et al 2002, Bullich et al 2004, Quarantelli et al 2004, Du 
et al 2005, Vanzi et al 2007). 
 
With the aim of minimizing its effect, some techniques apply small ROIs in the most 
active areas of the striatum, where the influence of PVE is lower. One example is the 
simple methodology based on cylindrical ROIs applied to a selected number of 
slices (Varrone et al 2004, Zubal et al 2007) and which is widespread in clinical 
routine. Other methods use large ROIs to cover the whole striatum and account for 
all the counts that have blurred out from the structure’s physical volume (Tossici-
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Bolt et al 2006). However, as these last methods prevent an individual 
quantification of the caudate and putamen regions this can prove unacceptable in 
some cases.  
 
The AQM post-reconstruction PVE compensation 
In AQM, we included a post-reconstruction PVE compensation based on the 
methodology described in Fleming et al 2004. This compensation requires the 
measurement of the total activity in the striatum and the calculation of the exact 
volume of each striatal region. The total activity in the striatum is calculated using 
ROIs which have been automatically expanded with respect to the original striatal 
regions. These expanded ROIs are large enough to ensure the inclusion of all the 
activity that has spread outside the physical volume of the structures because of 
PVE. The advantage of using an automatic expansion is a reduced operator-
introduced variability in their positioning. 
 
In this work, the original striatal ROI and the ROI located at the occipital region 
were defined by using the CT image of the phantom. To perform the quantification 
of the studies, all the reconstructed images were re-sampled to the high-resolution 
space where the ROIs had been defined. The exact volumes of the ROIs were 
calculated using the 3D ROI map. Compensation for PVE was carried out by 
expanding the original striatal ROI and calculating the mean activity concentration 
inside the expanded ROI. The total activity inside the original striatal ROI, 𝐴𝑆 , was 
calculated by removing the non-specific uptake from the total activity in the 
expanded ROI: 
 
𝐴𝑆 = 𝐴𝑆′ · 𝑉𝑆′ − 𝐴𝑂 · (𝑉𝑆 ′ − 𝑉𝑆) (5.3) 
 
Where 𝐴𝑆′  and 𝐴𝑂  are, respectively, the mean activity concentrations inside the 
expanded striatal ROI and the occipital region; 𝑉𝑆  and 𝑉𝑆 ′  are the volumes of the 
original and the expanded striatal ROI respectively. Note that this methodology 
assumes that the activity concentration of the occipital region is a good estimate of 
the non-specific uptake in the striatal ROI. 
 
If  𝐴𝑆  is the mean activity concentration in the striatal region, SUR can be written 
as: 
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By substituting equation (5.3) in the SUR definition, the SUR value after PVE 









The expansion of the striatal ROI was established by calculating the resolution of 
the reconstruction method. This value was obtained by using SimSET to project a 
linear source in air with only low-energy photons emission and reconstructing the 
projections using a transition matrix which included the modelling of the PSF. 
Simulation and reconstruction processes were performed using the same 
parameters as those selected for the studies. Then, the reconstructed image was re-
sampled to the high-resolution space and fitted to a Gaussian function to calculate 
the value of the standard deviation 𝜎. The value of the standard deviation in the 
high-resolution image depends on the collimator and stands for the resolution of 
the reconstruction. 
 
In this work, the striatal ROI was enlarged by 1𝜎. For the E.CAM parallel system, 𝜎 
had a value of 1.90 mm and for the HELIX fan-beam system, 𝜎 had a value of 1.75 
mm. The original and expanded striatum volume for both imaging systems is shown 
in table 5.3. 
 
Table 5.3 Enlargement applied to the original volume of the striatal ROI for each SPECT system. 
Imaging system σ (mm) Vs (ml) Vs’ (ml) ΔV (ml) 
E.CAM system 1.90 21.5 43.2 21.7 
HELIX system 1.75 21.5 38.8 17.3 
 
Figure 5.4 shows one central section of the numerical phantom where the ROIs 
corresponding to the original striatum, the reference occipital region and the 
expanded striatum have been drawn. 
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  a   b   c 
Figure 5.4 A central slice of the phantom showing: a the considered ROIs for the striatal nuclei 
(red) and the occipital region (light blue), b the expanded striatal ROI (green) and c the overlay of 
a and b. 
 
5.2.5 Absolute quantification 
AQM was designed to provide an absolute volumetric activity at each voxel of the 
image. However, the values at each voxel of the reconstructed image (𝜆𝑖) obtained 
from equation (5.1) cannot be considered as real activity values. It is therefore 
necessary to find a factor that transforms these calculated values into real activity, 
i.e. a factor that matches the counts of the simulated and the original projections. 
 
To calculate this factor, the reconstructed image at the first iteration, which had 
been corrected for attenuation, PSF and scatter, was selected as the input activity 
distribution of the SimSET simulator. The number of detected counts obtained in 
this simulation was compared with the total counts of the original projections. The 
factor that matches the counts of the simulated and the original projections was 
finally applied to the reconstructed image. 
 
5.3 Results and discussion 
5.3.1 Contribution of the high-energy photons to the projections 
The contribution of the primary, low-energy scattered photons and high-energy 
scattered photons to the total projections is shown in figure 5.5 for the two imaging 
systems studied and for a simulation corresponding to a SUR value of 6. 
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The numerical values shown in this figure highlight the undeniable significance of 
high-energy emission when pharmaceuticals labelled with 123I are used in brain 
SPECT imaging. Comparison of the projections obtained from the two cameras 
shows that the high-energy contribution is strongly dependent on the imaging 
system employed. When a LEHR parallel collimator is used with the parameters 
shown in table 5.1, more than 50% of the total photons detected correspond to 
scattered photons, with high-energy photons accounting for 40%. These results are 
in agreement with previous reported results for the same imaging system (Du et al 
2006). By contrast, for the LEHR fan-beam collimator studied, scattered photons 




Figure 5.5 A simulated projection of the striatal phantom with SUR of 6 for the E.CAM system 
(left) and the HELIX system (right). From top to bottom: primary, low-energy scattered photons, 
high-energy scattered photons and total photons detected. The numerical values of each 
contribution are also shown. Each image has been normalised to its maximum to improve its 
contrast. 
 
5.3.2 Effect of the corrections in the quantification 
To assess the effect of corrections for the degrading phenomena in the 
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OSEM: reconstruction without corrections 
OSEM-A: reconstruction with attenuation correction 
OSEM-AP: 3D-reconstruction with attenuation and PSF corrections 
OSEM-APS: 3D-reconstruction with attenuation, PSF and scatter corrections 
OSEM-APSV: OSEM-APS plus PVE compensation 
 
The calculated SUR values for the 30 simulated studies reconstructed applying the 




Figure 5.6 Calculated SURs obtained with different corrections for the E.CAM system (left) and 
the HELIX system (right): OSEM (hollow squares), OSEM-A (filled circles), OSEM-AP (hollow 
circles), OSEM-APS (filled triangles) and OSEM-APSV (hollow triangles). The dark solid line 
corresponds to the identity line. The light solid lines correspond to the linear fits for each 
correction. 
 
A linear relationship was found between calculated and true values in both imaging 
systems and for all the corrections applied. This relationship may be written as: 
 
𝑆𝑈𝑅𝑐𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 = 𝛼 · 𝑆𝑈𝑅𝑡ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙 + 𝛽 (5.6) 
 
Where 𝛼 is the slope of the regression line and 𝛽 stands for the intercept at the 
origin.  
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The mean value and standard deviations for 𝛼 and 𝛽, as well as the correlation 
coefficients of the linear fits are shown in table 5.4 for each imaging system and for 
all the corrections implemented. 
 
Table 5.4 Mean and standard deviations for 𝛼 and 𝛽 and correlation coefficients of the linear fits. 
Imaging system Correction level 𝜶 𝜷 R
2 
E.CAM system OSEM 0.36±0.00 −0.13±0.01 0.997 
 OSEM-A 0.44±0.00    0.05±0.02 0.997 
 OSEM-AP 0.55±0.01    0.02±0.02 0.997 
 OSEM-APS 0.69±0.01 −0.03±0.02 0.997 
 OSEM-APSV 0.97±0.01 −0.00±0.03 0.997 
HELIX system OSEM 0.42±0.00 −0.03±0.01 0.998 
 OSEM-A 0.50±0.01    0.19±0.02 0.997 
 OSEM-AP 0.60±0.01    0.20±0.02 0.997 
 OSEM-APS 0.75±0.01 −0.00±0.03 0.997 
 OSEM-APSV 1.00±0.01    0.06±0.03 0.997 
 
These results demonstrate that recovered SUR values have a linear relationship 
with the true specific ratios for both cameras and for each correction applied. It 
should be pointed out that the relationship between measured and true SUR values 
is mainly linear with a nonzero intercept at the origin. For high nominal SURs, the 
slope of the linear regression determines the SUR recovery factor. Nevertheless, for 
low nominal SURs, the value of the intercept at the origin becomes a determinant 
parameter as it induces a bias in the recovery factor. 
 
Our findings corroborate that quantitative results are dependent on the imaging 
system used in the acquisition when the reconstruction method does not include all 
the corrections for all the degrading phenomena (Koch et al 2005, 2006). 
 
For all the cases with the exception of OSEM-APSV, the HELIX camera shows a value 
of 𝛼 that is, on average, 6% higher than that of the E.CAM camera. In any case, 
although both imaging systems achieve different recovery factors with the same 
corrections, there is a continuous improvement as the corrections are progressively 
included. For both cameras, the successive corrections raise the value of 𝛼 from 36 
to 97% for the E.CAM system (total increase of 61%) and from 42 to 100% (total 
increase of 58%) for the HELIX system. 
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PVE compensation plays a major role in the recovery of the true specific ratios as it 
may induce an improvement of approximately 25–30% in 𝛼 values depending on 
the imaging system used (see table 5.5). The scatter correction also plays an 
important part as it increases 𝛼 values by 15%. PSF and attenuation corrections are 
the least significant corrections with improvements of around 10 and 8%, 
respectively. 
 
Table 5.5 Improvement achieved in 𝛼 with each individual correction for each SPECT system. 
 E.CAM system  HELIX system  
Correction ∆𝜶 (%)  ∆𝜶 (%)  
Attenuation 8%  8%  
PSF 11%  10%  
Scatter 14%  15%  
PVE 28%  25%  
 
On the other hand, the two systems differed in the behaviour of the 𝛽 values 
depending on the correction applied. One important fact is that scatter correction 
causes 𝛽 to fall close to 0. The addition of the PVE compensation induces a slight 
increase in 𝛽, which has no relevance in the recovery factor of both cameras. 
Furthermore, PVE compensation minimizes the differences in 𝛼, so that both 
imaging systems attain a recovery factor of around 100%. Thus, our study suggests 
that recoveries close to 100% may be obtained by expanding the original striatal 
ROI in 1σ of the spatial resolution of the reconstruction. 
 
5.3.3 Visual effect of the scatter correction 
Figure 5.7 shows the reconstructed image of a central slice at the first iteration of 
the reconstruction algorithm for two cases: OSEM-AP and OSEM-APS. 
 
Improvement is clearly visible when the scatter correction is included. Note that 
scattered photons detected degrade the image quality as they reduce the signal-to-
noise ratio and the resolution in the projections. The first iteration is the most 
suitable for visual assessment, although the most accurate quantification results are 
achieved at a higher number of iterations. 
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Figure 5.7 Reconstructed central slice of the striatal brain phantom for the E.CAM system (top) 
and the HELIX system (bottom). For each camera, the images correspond to a nominal SUR of 4.7 
and to a reconstruction using OSEM-AP (left) and OSEM-APS (right). 
 
5.3.4 Absolute quantification results 
Figure 5.8 shows the bias between calculated and nominal mean activity 
concentration values as a function of nominal SUR. The bias from the true values 
was calculated as: 
 
𝐴𝑏𝑖𝑎𝑠  % =
𝐴𝑐𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 −𝐴𝑛𝑜𝑚𝑖𝑛𝑎𝑙
𝐴𝑛𝑜𝑚𝑖𝑛𝑎𝑙
× 100 (5.7) 
 
Since the quantification of the radiotracer uptake is less sensitive to PVE in the 
occipital region than in the striatum because of its size (Du et al 2005), PVE 
compensation is omitted for the occipital region and only the bias in the striatum 
after PVE compensation is reported. 
 
For the HELIX system and for low values of SUR (approximately between 0.5 and 
1), there is a slight positive bias in the striatum when PVE is compensated and a 
slight negative bias in the occipital region. This causes an overestimation of the 
calculated SUR in patients with severe reduction in the DAT density. 
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             a                             b 
Figure 5.8 The activity concentration bias (%) between calculated and nominal mean activity 
concentration values vs nominal SURs for (top) the striatum when OSEM-APS (hollow squares) 
and OSEM-APSV (hollow triangles) are used, and (bottom) the occipital region when OSEM-APS is 
used (hollow squares). Biases are shown for: a the E.CAM system and b HELIX system. Horizontal 
lines represent a percent bias equal to 0. 
 
When reconstruction includes attenuation, PSF and scatter corrections, the 
calculated mean activity concentration in the striatum is underestimated by about 
35% for the E.CAM system and about 20% for the HELIX system, whereas the 
maximum percent bias in the occipital region is about 5% for both cameras. PVE 
compensation proves to be effective in minimising the bias in the calculated mean 
activity concentration in the striatum, reducing errors to about 5% for both 
systems. These results indicate that PVE compensation in the striatum is necessary 
for absolute quantification. PVE compensation in the occipital region is not 
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Nominal SUR values can be obtained in SPECT neuroimaging provided accurate 
compensations for all the image-degrading effects are included in the quantification 
process. 
 
In this chapter we have described, implemented and evaluated AQM, a complete 
methodology to compensate for all the image-degrading phenomena, including PVE. 
The effect of the different compensations on SUR quantification has also been 
assessed. Our findings show that PVE compensation stands out as the most relevant 
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6 Semi-quantification of 
 dopaminergic 
 neurotransmission 
 SPECT studies with 123I 
 for clinical routine 
 
6.1 Introduction 
Chapter 5 presented a complete methodology that allows recovery of the true 
activity concentration in the striatum after correction for all the degrading effects 
involved in dopaminergic neurotransmission SPECT imaging with 123I-labelled 
radioligands. Although absolute quantification can be achieved using this 
methodology, some of its computational and technical requirements still prevent a 
direct implementation in clinical practice. The length of time required for 
reconstruction is a handicap as well as the need for MR images, which are not 
usually included in the diagnostic protocols for PD and schizophrenia, for ROI 
definition. In addition, scatter correction is based on MC simulation which requires 
the use of a dedicated code that incorporates the characterisation of the imaging 
system employed. 
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In clinical routine, simple, reliable and rapid methods are needed to extract high-
quality quantitative information from the studies. Quantitative information 
improves sensitivity, aids diagnosis and patient follow-up and assesses the 
response to therapy. In neurological practice, a semi-quantitative analysis is highly 
recommended to objectively assess striatal DAT binding (Darcourt et al 2010) or 
striatal D2 receptor binding (van Laere et al 2010) and several semi-quantification 
methodologies have been proposed (Badiavas et al 2011). Some of these methods 
use anthropomorphic phantoms to demonstrate their reliability by means of a 
comparison with the true values (Calvini et al 2007, Dickson et al 2012). 
 
In these studies, a linear relationship between measured and true striatal to 
background ratios was observed. This linear relationship was found to be 
dependent on the imaging system used during acquisition and on the 
reconstruction method applied (Koch et al 2006, Crespo et al 2008, Tossici-Bolt et 
al 2008, 2011). Some research groups have used the linear relationship calculated 
for a phantom to standardise all the studies carried out using the same camera 
system and protocols as the phantom (Varrone et al 2013). However, the 
applicability of a single set of parameters of the linear model to any subject, 
regardless of morphological differences and striatal specific uptake, has not been 
validated. Under real conditions, both anatomical variability between subjects and 
the PVE may affect the linear behaviour between observed and true values 
(Dewaraja et al 2001). 
 
The aim of this chapter is to evaluate whether a linear relationship could also be 
established for a group of subjects with normal and pathological striatal uptake 
values. In this evaluation MC simulation was used, thus facilitating the analysis of a 
large variety of anatomical and tracer uptake cases and the evaluation of the 
reliability of the methodology applied. 
 
The MC simulation of a test group of studies corresponding to 23 different subjects 
with non-negligible anatomical differences was performed. Quantification was 
carried out using the actual striatal ROIs derived from MRI and striatal ROIs 
derived from the AAL map (Tzourio-Mazoyer et al 2002). Caudate and putamen 
were quantified separately. The study focused on the influence of anatomical 
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6.2 Materials and methods  
6.2.1 Numerical brain maps for the simulated test studies 
The numerical dataset group was generated using 3D T1-weighted MR images 
(256x256x116 matrix size; 0.9375x0.9375x1.5 mm3 voxel size) corresponding to 
23 subjects free of cerebral abnormalities. A CT image of an anthropomorphic 
striatal brain phantom (Radiology Support Devices, RSD. Inc, Long Beach, CA), 
256x256x196 matrix size, with a voxel size of 0.89x0x89x0.89 mm3, was co-
registered to each MR image in order to get a bone structure for each subject. The 
scans were segmented to generate subject-specific activity and attenuation maps 
that were then used to simulate the projections. The main steps in this procedure 
are outlined below. 
 
Activity maps 
To generate the activity maps, MR images were segmented into grey matter, white 
matter and cerebrospinal fluid using Statistical Parametric Mapping (SPM2, 
Wellcome Department of Imaging Neuroscience, London, UK). Non-specific uptake 
was considered to be the same for grey and white matter, whereas the activity in 
the cerebrospinal fluid was assumed to be zero. The striatum was segmented from 
the MR images. The FIRST segmentation tool from FSL (FMRIB, University of 
Oxford, UK) (Patenaude et al 2011) was used to select caudate and putamen nuclei 
of each subject. 
 
A comprehensive range of possible striatal to background uptake ratios was drawn 
up, modelling normal and pathological distributions of 123I-FP-CIT. To this end, 
tracer uptake in caudate and putamen was simulated, assuming that the activity 
concentration in caudate could not be lower than that in putamen. A wide variety of 
tracer uptakes in caudate and putamen were simulated, including normal and 
pathological cases. Activity concentration was considered to be uniform within the 
whole caudate, putamen and background. 
 
Attenuation maps 
The set of 23 MR images was spatially normalised to the T1-weighted template 
from the MNI, which is included in SPM. A CT image was also obtained from an 
anthropomorphic striatal brain phantom and normalised to the transmission 
template of SPM. A 12-parameter affine transformation was considered. Finally, the 
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inverse transformations of the normalised MR images were applied to the 
normalised CT so as to obtain a CT image fitted to each MR (Aguiar et al 2008). 
 
To generate the attenuation maps, the normalised CT image was segmented into 
brain and bone using a threshold value. Attenuation maps were obtained by setting 
the corresponding attenuation coefficients for brain tissue and bone depending on 
the energy of the simulated photons. Figure 6.1 shows an axial view of the original 
MR image together with activity and attenuation maps of one of the subjects used 
for the simulation. 
 
 
            a                b                       c 
Figure 6.1 Axial views of a randomly selected subject, corresponding to: a original MR image, b 
activity distribution map and c attenuation map. 
 
6.2.2 Anatomical variability between simulated test studies 
The anatomical variability between simulated test studies was quantitatively 
evaluated by determining the volume of the striatal regions of each subject. 
 
The sample proved to contain non-negligible anatomical variations. The volume of 
the whole striatum ranged from 19 ml to 27 ml with a coefficient of variation of 9%. 
Caudate showed the greatest differences between hemispheres, with a 5% 
difference between the mean volumes of the right and left caudate. Maximum 
differences in volume between the test subjects ranged from 37% for the right 
putamen to 49% for the right caudate. The descriptive statistical parameters of 
these volumes are shown in figure 6.2. 
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Figure 6.2 Box plots of the volumes of the different striatum regions. LC: left caudate; RC: right 
caudate; LP: left putamen; RP: right putamen. 
 
6.2.3 SPECT imaging system and SimSET simulation 
SPECT projections were simulated for a Siemens E.CAM gamma camera equipped 
with a LEHR parallel-hole collimator (hexagonal holes 24.05 mm in length with a 
radius of 0.641 mm and a septal thickness of 0.16 mm).  
 
Subject-specific projections were obtained using the new version of SimSET, which 
adapts the code to 123I-labelled radioligands simulation (see chapter 4). Six 
sinograms with a high signal-to-noise ratio were generated for each of the 23 
subjects, resulting in a simulated database of 138 studies. SUR values between 0.5 
and 10 for caudate and putamen were selected in such a way that a well-distributed 
sample was obtained. Simulated studies included normal uptake and pathological 
cases. The pathological cases covered a wide range of possible clinical situations: 
uniform global striatal uptake reduction and a variety of uptake asymmetries 
between caudate and putamen, both unilateral and bilateral. Figure 6.3 shows the 
theoretical SUR values for caudate and putamen for each study. 
 
Studies with a high signal-to-noise ratio were chosen since the aim was to evaluate 
the PVE without noise interference and earlier studies have shown that differences 
in the mean SUR values of simulations due to noise are negligible (Cot et al 2005). 
Acquisition parameters were selected according to routine conditions. A total of 
128 projections were acquired over 360° using a bin size of 3.9 mm and a 15% 
energy window. The radius of rotation was considered to be 14.5 cm. 
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Figure 6.3 Theoretical SUR values for caudate and putamen for each of the 138 simulated studies 
(hollow circle for left hemisphere and cross for right hemisphere). Asymmetries between left and 
right hemispheres are seen as non-coincidences between circles and crosses.  
 
6.2.4 Reconstruction of the simulated projections 
Reconstruction was performed using FBP and the OSEM algorithm. In FBP 
reconstruction, MC projections were filtered using a two-dimensional Butterworth 
filter (order 5; cut-off frequency 0.5 cm-1) and then reconstructed by FBP with a 
ramp filter. Datasets were corrected for attenuation according to Chang’s method 
and using the attenuation maps for shape contouring. An effective linear 
attenuation coefficient of 0.10 cm-1 was used to generate the uniform attenuation 
maps, as recommended in the EANM guidelines (Darcourt et al 2010) for 123I in the 
absence of scatter correction (Zaidi and Montandon 2002).  
 
MC projections were also reconstructed using the OSEM algorithm with 8 subsets 
and 3 iterations (Koch et al 2005) and included both attenuation and ideal scatter 
correction. Attenuation correction was implemented using the corresponding 
attenuation maps with attenuation coefficients of 0.149 cm-1 for brain and 0.307 
cm-1 for bone. The ideal scatter correction was achieved by considering only the 
primary photons in the projections. Reconstructed images consisted of 128x128x45 
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6.2.5 Quantification methodology 
Reconstructed images were quantified using the actual striatal ROIs and ROIs 
derived from the AAL map defined in the MNI standard space.  
 
In the first approach, quantification was performed directly over the reconstructed 
SPECT studies. To this end, the striatal cavities segmented from the original MR 
images were resized to fit with the reconstructed images. The reference ROI was 
defined on the occipital region of the MR template of SPM. This occipital ROI was 
placed on each study by applying the inverse transformations of the previously 
normalised MR images. Finally, the occipital ROIs were resized to fit the 
reconstructed images. Since simulated projections had a high signal-to-noise ratio 
and the quantification ROIs corresponded to those used in the simulation, 
variability was exclusively associated to anatomical differences and PVE. 
 
In the second approach, each reconstructed image was normalised to a template 
defined in the MNI standard space. This template was obtained from 14 normal 
control studies simulated using 14 subjects different from those employed to 
generate the benchmark sample (see figure 6.4). 
 
 
Figure 6.4 Coronal (top left), sagittal (top right) and axial (bottom) views of the SPECT template. 
 
Normalisation was performed in two steps. In the first step, images were 
normalised to the template using SPM. In the second step, a fine adjustment of the 
reconstructed striatum of each hemisphere was made by optimizing the local 
correlation coefficient (LCC) with the corresponding hemisphere of the template 
(Pavia et al 1994). To generate the ROIs, we selected those corresponding voxels 
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from the striatal AAL ROIs which were common to both hemispheres, thus, 
generating a symmetric ROI for caudate and putamen. These symmetric AAL ROIs 
(AALsym) were finally used to quantify the MNI normalised studies. 
 
Figure 6.5 shows the MRI and AALsym ROIs on a central slice of a test study 
reconstructed using OSEM.  
 
 
Figure 6.5 A central slice of a reconstructed study using OSEM, showing the striatal MRI ROIs 
(left) and the AALsym ROIs (right). Note that the image on the right is in the MNI standard space.    
 
Figure 6.6 shows the reference region on a MR image of one of the subjects. 
 
 
                a     b              c 
Figure 6.6 Axial a, sagittal b and coronal c views of a MR image of a randomly selected subject 
showing the reference ROI defined on the occipital region. 
 
6.2.6 Standardisation methodology 
From studies performed using phantoms, it has been suggested that the calculated 
striatal SUR ( calsSUR ) for a subject after reconstruction, with or without 
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corrections for the degrading phenomena, can be written as (Koch et al 2006, 




s SURSUR ·   
(6.1) 
 
Where   is the slope of the regression line, sSUR  is the true value in the striatum 
and 
 
stands for the intercept. However, if this model is applied to individual 
caudate or putamen, the influence of adjacent regions is not taken into account. 
 
If the contribution of the counts from the adjacent regions (caudate or putamen) 
are included in equation (6.1), a new multiple linear model for the individually 
calculated SURs in caudate and putamen ( calcSUR  and 
cal
pSUR ) can be defined as 





























































Where   coefficients represent the fraction of true SUR ( cSUR  or pSUR ) 
recovered in the corresponding structure, k  coefficients express the fraction of 
true SUR from adjacent regions that contributes to the calculated SUR and B  terms 
are constants which depend on the reconstruction method. This multiple linear 
model is inspired by the work by Rousset et al (1998) for PVE correction of mean 
activity values between adjacent ROIs.  
 
In the current study, we assessed how well the SULS model (valid for an individual) 
describes the relationship between calculated and true SUR values for each 
individual when we use a single set of parameters obtained as the average values of 
a group of subjects. The simple linear model was also applied to check its 
suitability. Thus, standardised values were obtained from the simple linear model 
by applying the inverse of equation (6.1) and from the multiple linear model by 
applying the inverse of the system shown in (6.2). Differences between 
standardised and true values were quantified using the chi-square value ( 2 ). 
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Where i  is the standardised value of study i , i̂  is the true SUR and N  is the 
number of studies. 
 
6.3 Results and discussion 
6.3.1 Contribution of PVE to the measured SUR values 
Contribution of PVE to the measured SUR values was studied by performing two 
different sets of simulations. One set considered that only caudate had specific 
uptake while the other one considered that only putamen had it. Ideally, 
reconstructed images should only show high activity concentration in caudate and 
putamen, respectively. However, specific uptake was also found in adjacent regions 
because of PVE and non-ideal scatter correction. 
 
Figure 6.7 shows a central slice of the FBP-reconstructed image of a study 
simulated under the two situations described. Images a and b in figure 6.7 
correspond to simulations with specific uptake only in caudate or in putamen, 
respectively. Image c shows the overlay of the previous ones. 
 
In agreement with the previous description of the multiple linear model, this figure 
shows that detected photons that should increase the counts in each of these 
structures also contribute to the counts in adjacent regions, thereby masking the 
real activity in all these areas. 
 
The counts that spill into caudate from putamen cause calcSUR  to inflate by a value 
which is proportional to pSUR . The same phenomenon occurs in putamen, where 
counts that spill in from caudate inflate calpSUR  in the regions closest to caudate. 
The area most affected by the spill-out of counts from caudate is the anterior 
putamen. In the central putamen this influence is hardly noticeable and in the 
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            a      b             c 
Figure 6.7 A central slice of a study using FBP, showing the spill-out of counts from caudate to 
putamen a and from putamen to caudate b. In c, the overlay of a and b is shown. 
 
For a randomly selected study quantified using FBP reconstruction and MRI ROIs, 
the PVE between adjacent regions makes calcSUR  increase linearly with pSUR , as 
13.2035.0  p
cal
c SURSUR  when cSUR  has a nominal value of 6. The same 
phenomenon applies vice versa with 14.2036.0  c
cal
p SURSUR  when pSUR   
has a nominal value of 6. These results show that the influence of PVE causes the 
calculated SUR to rise to 9% when the adjacent region varies from a nominal value 
of 0 to 6. 
 
Thus, the qualitative and quantitative results derived from this study suggest that 
PVE between the striatal regions should be taken into account when defining the 
relationship between calculated and true SUR values. 
 
6.3.2 Measured individual SUR values for caudate and putamen 
Figure 6.8 shows calcSUR  and 
cal
pSUR  from each hemisphere against their 
corresponding true values for the 138 simulated test studies. Results are shown for 
the two reconstruction methods (FBP and OSEM) and the two sets of ROIs applied 
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(MRI ROIs and AALsym ROIs). Note that 138 studies generate a database of 276 
values for each striatal region (138 studies x 2 hemispheres). 
 
 
Figure 6.8 Calculated SUR values in caudate and in putamen against their corresponding true 
values for the two reconstruction methods and the two different ROIs (MRI and AALsym). Hollow 
circles indicate reconstruction using FBP and filled circles indicate reconstruction using OSEM. 
Regression lines are shown as solid lines. 
 
Tables 6.1 and 6.2 show, respectively, the mean and standard error for the 
parameters of SULS obtained by multiple linear regression of the 138 simulated 
studies and the slope and intercept (with their standard errors) if a simple linear 
relationship is applied. Parameters are shown for each reconstruction and 
quantification method and for each striatal region. 
 
The high values of R2 found for all the quantification methods applied indicate that 
not only is the relationship between the calculated and the true striatal values for 
each individual one of linearity, but also the global behaviour of the whole group of 
patients, even for individual striatal regions. This would indicate that, despite 
anatomical differences between subjects and the specific effect of PVE in each 
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individual, the global behaviour of striatal uptake may be described using some 
common parameters. 
 
Table 6.1 Mean and standard errors for the parameters obtained by multiple linear regression 





 Multiple linear regression (SULS)  
   k  B  2R   
Caudate FBP-MRI  0.332 ± 0.004  0.040 ± 0.005 0.053 ± 0.018 0.985  
 FBP-AALsym  0.291 ± 0.007  0.060 ± 0.007 -0.113 ± 0.026 0.963  
 OSEM-MRI  0.514 ± 0.006  0.034 ± 0.006 -0.106 ± 0.025 0.987  
  OSEM-AALsym  0.427 ± 0.008  0.057 ± 0.008 -0.171 ± 0.031 0.974  
Putamen FBP-MRI  0.344 ± 0.005  0.039 ± 0.005 0.104 ± 0.021 0.980  
 FBP-AALsym  0.324 ± 0.005  0.052 ± 0.005 0.003 ± 0.020 0.980  
 OSEM-MRI  0.545 ± 0.006  0.021 ± 0.005 0.040 ± 0.022 0.990  
 OSEM-AALsym  0.514 ± 0.007  0.049 ± 0.007 -0.082 ± 0.028 0.984  
 
Table 6.2 Mean and standard errors for the parameters obtained by simple linear regression 





 Simple linear regression  
     2R  
 
Caudate FBP-MRI  0.362 ± 0.003  0.033 ± 0.020 0.980  
 FBP-AALsym  0.338 ± 0.005  -0.143 ± 0.030 0.952  
 OSEM-MRI  0.540 ± 0.004  -0.123 ± 0.026 0.986  
  OSEM-AALsym  0.471 ± 0.005  -0.200 ± 0.033 0.969  
Putamen FBP-MRI  0.376 ± 0.004  0.208 ± 0.017 0.976  
 FBP-AALsym  0.366 ± 0.004  0.142 ± 0.018 0.973  
 OSEM-MRI  0.563 ± 0.004  0.097 ± 0.017 0.989  
 OSEM-AALsym  0.553 ± 0.005  0.050 ± 0.022 0.981  
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The multiple linear model takes into account the PVE phenomena that occurs 
between adjacent striatal regions. The single set of parameters obtained for the 
SULS model by multiple linear regression adequately describes the relationship 
between calculated and true SUR values providing accurate results and high 
correlation coefficients for both caudate (R2 in the range 0.963-0.987) and putamen 
(R2 in the range 0.980-0.990). On the other hand, results in table 6.2 show that a 
simple linear relationship can also be established when the PVE is not explicitly 
included in the model. In this case, however, R2 values are slightly lower than those 
of the multiple linear model (R2 for caudate in the range 0.952-0.986 and R2 for 
putamen in the range 0.973-0.989). 
 
It should be noted that these results were obtained assuming a uniform activity 
distribution within the whole caudate and putamen. In the case of non-uniform 
activity concentration along these regions, the quantitative results might be slightly 
modified because of changes in PVE due to intra-regional tracer distribution. 
 
6.3.3 Estimation of the true individual SUR values 
Standardised values for individual caudate and putamen were obtained using the 
multiple linear model as well as the approximation given by the simple linear 
model. An estimation of the true SUR for caudate and putamen for each individual 
was calculated by applying the inverse of the regression systems shown in 
equations (6.1) and (6.2) using the parameters of tables 6.2 and 6.1 for the simple 
and multiple linear model. 
 
Figure 6.9 shows the estimated SURs against the true values for the 138 simulated 
tests. Estimated SURs were obtained using the parameters of SULS and those of the 
linear regression. The linear fits of the estimated SURs are shown in table 6.3. 
 
As table 6.3 shows, more accurate results and lower variability were found when 
the SULS model was applied, especially when FBP was used. For FBP-MRI, 2  
values diminished by 18% for caudate and by 30% for putamen when multiple 
instead of simple linear regression was used. For FBP-AALsym, 
2  values 
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Figure 6.9 Standardised cSUR and pSUR  against the true values obtained by using the SULS 
model (filled circles) and the simple linear regression model (hollow circles). Regression lines are 
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Table 6.3 Correlation coefficients of the linear fits of the standardised 
cSUR  and pSUR calculated 
applying the SULS model and the simple regression model. 






Multiple linear regression  
 
 




2   2R  
2   
Caudate FBP-MRI 0.984 4.28  0.980 5.24  
 FBP-AALsym 0.955 11.79  0.952 12.44  
 OSEM-MRI 0.986 3.48  0.986 3.62  
 OSEM-AALsym 0.970 7.13  0.969 7.42  
Putamen FBP-MRI 0.979 7.36  0.976 10.50  
 FBP-AALsym 0.979 6.55  0.973 12.57  
 OSEM-MRI 0.990 3.27  0.989 3.62  
 OSEM-AALsym 0.983 5.18  0.981 6.96  
 
Differences were found to be less important when OSEM was applied (4-10%) with 
the exemption of OSEM-AALsym for putamen, where multiple linear regression 
diminished 2  value by 26%. 
 
The goodness of the fit using the SULS model improves that of the simple linear 
model, especially for those studies where p
c
p SURk   and c
p
c SURk   terms in 
equation (6.3) have a relevant contribution to the calculated calcSUR  and 
cal
pSUR , 
respectively. Thus, for caudate the SULS model will be particularly appropriate for 
studies with high pSUR  values such as those corresponding to healthy controls 
(maximum improvement was found for FBP-MRI with a reduction of almost 50% in 
2  value). For putamen, the SULS model will provide more accurate values than 
the simple linear model in those studies where there is a large asymmetry between 
caudate and putamen (maximum improvement was found for FBP-AALsym with a 
reduction of 85% in 2 value). 
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It should be pointed out that the set of parameters applied to each model was 
obtained by linear regression of the dataset and, as a consequence, was fully 
representative of the average performance of the test studies simulated in this 
work. In a clinical context, anthropomorphic striatal phantoms could still be used to 
determine those parameters, provided they can be considered representative of the 
average anatomy of the population. Parameters for both the linear and the SULS 
models should be obtained from the phantom using the same protocol as that 
applied to the patient studies, i.e. imaging system, acquisition conditions, 
reconstruction algorithm and quantification method. 
 
In summary, reconstruction and quantification methods were found to have a high 
impact on the linearity of the relationship between calculated and true values, and 
on the accuracy of the standardised results. The use of iterative reconstruction in 
conjunction with precise attenuation and scatter corrections improved linearity 
and accuracy with respect to FBP using an effective linear coefficient. The 
application of generic ROIs instead of subject specific ROIs, yielded inaccuracies 
due to the normalisation process and morphological differences between the 
generic ROI and the actual ROI of each subject. In general, linearity and accuracy 
were found to be lower when using generic ROIs than when the gold standard MRI 
ROIs were used, especially in caudate. These results indicate that wherever 
available, the use of subject specific ROIs derived from a co-registered MRI scan or, 
in the future, from hybrid SPECT/MRI systems should be the method of choice. 
 
6.4 Conclusions 
A number of works using anthropomorphic phantoms have shown a linear 
relationship between calculated and true SUR values for a subject. As a 
consequence, several standardisation methods use the linear relationship 
calculated for a phantom to standardise the SUR values. However, these methods 
take it for granted that the parameters derived from the phantom characterization 
are valid for any subject, regardless of morphological differences and whatever the 
uptake ratio between the caudate and putamen nuclei of the subject.  
 
In this chapter we have evaluated the feasibility of this assumption using a dataset 
of simulated studies which mimicked studies of pathological and healthy subjects. 
Our findings show that anatomical variability does not compromise the general 
linear model between calculated and true SUR values for any of the quantification 
methods applied. A single set of parameters obtained for the SULS model by 
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multiple linear regression adequately describes the relationship between 
calculated and true SUR values for both caudate and putamen. This behaviour can 
also be described by a simple linear model, albeit with slightly lower correlation 
coefficients. Thus, this work demonstrates that a simple linear relationship with a 
single set of parameters can be used to standardise the calculated SUR values of 
those studies carried out using the same imaging equipment and following the 

























In the previous chapters the difficulties associated with an accurate quantification 
of dopaminergic neurotransmission SPECT images have been evaluated and two 
different methodological strategies to achieve reliable quantitative values have 
been proposed. The first methodology allows recovery of the true activity 
concentration in the striatum after correcting for all the degrading effects. In this 
case, computational and technical requirements limit the applicability of this 
methodology to clinical research trials. The second methodology consists of a semi-
quantification method that offers standardised values in the clinical routine. Both 
quantification methodologies have been evaluated using MC simulation, which 
allows us to know the ground truth.  
 
The works developed in chapters 5 and 6 have permitted, inter alia, a study of the 
contribution of scattered photons to the projections in different imaging systems, 
an evaluation of the importance of correcting for degradations in the quantification 
accuracy, and have demonstrated that standardisation can be achieved using a 
simple linear regression model. Besides the above methodological works based on 
MC simulation, these methods have also been applied in research and clinical 
frameworks with real studies. The aim of these works was to extract reliable 
quantitative information from the SPECT images to help in the development of 
antipsychotic drugs and in the diagnosis of neurological and psychiatric diseases 
associated with dysfunction of the dopaminergic system (see chapter 1). 
 





In this chapter, the contribution to these studies of the methodologies presented in 
this thesis is briefly discussed. Table 7.1 summarises the main methodological 
issues of the three studies presented below. 
 
Table 7.1 Main methodological criteria followed in the three works with real studies. 
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Quantification 
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Neuroimage 
Research PRISM FBP with attenuation 
correction 
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OSEM with attenuation 
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OSEM with attenuation, 
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Mané et al 2011 
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standard space of a 
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7.2 Impact of scatter correction on D2 receptor occupancy 
measurements using 123I-IBZM SPECT: Comparison to 
11C-Raclopride PET  
7.2.1 Aim of the study 
In 2009, Catafau et al raised the question of the differences found in striatal 
dopamine D2 receptor occupancy (RO) values when measured using SPECT or PET 
imaging. Reported D2 RO values induced by antipsychotic drugs reveal that 





measured values with 123I-IBZM SPECT tend to be lower than those measured with 
11C-Raclopride PET for any given dose medication. 
 
In 2010, Bullich et al gave response to this question. The authors suspected that 
image degrading factors that are not routinely corrected in SPECT and, specifically, 
scatter of low and high-energy photons were responsible for this difference. Thus, 
we used the AQM method presented in chapter 5 to reconstruct the SPECT images 
with accurate scatter compensation. 
 
7.2.2 Materials and methods 
To clarify this issue, the authors designed a precise research work to measure D2 
RO in the same subjects using both 123I-IBZM SPECT and 11C-Raclopride PET. A total 
of 26 studies from 9 healthy subjects and 17 patients with schizophrenia recruited 
in the study above mentioned (see Catafau et al 2009) and an experimental striatal 
phantom were included in this study. 
 
SPECT projections were acquired with a Picker PRISM 3000 S gamma camera 
equipped with a fan-beam collimator (see chapter 4 for a detailed description of the 
imaging system). To identify the origin of the quantitative differences between both 
imaging techniques, we reconstructed the SPECT images using different correction 
levels: FBP with attenuation correction applying the Chang’s algorithm, OSEM with 
attenuation and PSF corrections and, finally, OSEM with attenuation, PSF and 
scatter corrections. Reconstructions using OSEM were performed using the AQM 
method for 123I-labelled radioligands. PET images were reconstructed elsewhere 
using FBP and corrected for attenuation, scatter, random coincidences and dead 
time. PET transmission scans were obtained to define the attenuation maps used in 
the attenuation correction. 
 
In addition, each subject underwent a MRI scan. Individual MR images were used to 
manually delineate subject specific anatomical ROIs. Quantification was performed 




123I-IBZM SPECT images from the 26 subjects and from the experimental phantom 
were quantified in our laboratory using the AQM method presented in chapter 5 for 





the absolute quantification of SPECT studies with 123I-labelled radioligands. We 
calculated the scatter estimation for each individual subject using the new version 
of the MC code SimSET adapted to the simulation of 123I SPECT studies. Activity 
maps were derived from the reconstructed images without scatter compensation 
and the attenuation maps were obtained from PET transmission scans. The 
characterisation of the gamma camera was already included in the collimator 
module of SimSET (see chapter 4 for a detailed description). Note that, in this work, 
AQM was used to quantify D2 RO, thus demonstrating its applicability in studies of 
the postsynaptic functioning. 
 
SPECT D2 RO values were found to be significantly lower when compared to PET 
when FBP with attenuation correction, and OSEM with attenuation and PSF 
corrections were applied, with differences of about 20%. In contrast, when scatter 
correction was included in the reconstruction algorithm, differences diminished to 
approximately 6%. Thus, it was concluded that scatter correction plays a major role 
in explaining the differences between D2 RO values measured using 123I-IBZM 
SPECT and 11C-Raclopride PET and should be taken into consideration when 
interpreting the results.   
 
In this work, the accuracy of the scatter estimation achieved using AQM was 
essential for understanding the origin of the bias between SPECT and PET 
measurements. This finding is important for drug development and for the 
understanding and interpretation of imaging literature on D2 RO. 
 
7.3 A 4-year dopamine transporter (DAT) imaging study in 
neuroleptic-naive first episode schizophrenia patients  
7.3.1 Aim of the study 
Mané et al in 2011 presented a longitudinal study evaluating the course of DAT in 
schizophrenia. The main objective of the authors was to test the hypothesis that 
schizophrenia is associated with an accelerated loss of striatal DAT binding over 
the course of the illness. 
 
7.3.2 Materials and methods 
To test this hypothesis, the authors carried out a 4-year DAT SPECT follow-up 
clinical study with 14 patients and 7 controls. 







Figure 7.1 Steps followed to create the 
123
I-FP-CIT SPECT template. 
MRI scan is coregistered





MRI scan SPECT study
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studies are normalised to 
the MNI space 
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The average SPECT image 
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SPECT studies were acquired with an Elscint HELIX gamma camera equipped with 
a LEHR fan-beam collimator (see chapter 5 for a detailed description of the imaging 
system) and using 123I-FP-CIT. Images were reconstructed elsewhere using FBP 
with a Metz filter for partial recovery of the spatial resolution and without 
additional corrections for degradations. A MRI follow-up study was also carried out. 
 
To quantify the SPECT images, we created a 123I-FP-CIT SPECT template from the 
subjects that took part in the study (see figure 7.1). The template was created 
following a number of steps. Firstly, MR images were coregistered to the SPECT 
images for each subject using SPM. Secondly, MR images were normalised to the 
T1-weighted template defined in the MNI standard space and the same 
transformations were applied to the SPECT images. Thirdly, normalised SPECT 
images were summed together and averaged out. Finally, a 3D Gaussian filter of 8 
mm (Full Width Half Maximum) was applied to obtain a suitable template. 
 
A total of 16 slices from the template were visually selected as representing the 
central part of the striatum. We defined the striatal ROIs and the reference ROI over 
the selected slices from the template. To quantify the striatal area, we drew six 
prismatic ROIs using the ImageJ software (area: 36 mm2, height: 32 mm). ROIs were 
placed in caudate, anterior putamen and posterior putamen from each hemisphere. 
Additionally, an irregular reference ROI was drawn in the occipital cortex covering 
both hemispheres (area: 27.24 cm2, height: 32 mm). 
 
 










Each SPECT image was normalised to the template using SPM. The location of the 
striatal ROIs was manually adjusted, where necessary, for each study to fit the ROIs 
in the middle of the highest activity zones of caudate and putamen, far away from 
the edge to minimise PVE. Figure 7.2 shows a central slice of the SPECT template 
with the ROIs used to quantify the studies. 
 
7.3.3 Discussion 
123I-FP-CIT SPECT images from 21 subjects were quantified in our laboratory using 
geometrical ROIs defined on a SPECT template. In this work, we adapted the 
methodology developed in chapter 6 for the semi-quantification of SPECT images 
based on standardised ROIs defined on a template to the resources available in a 
real clinical situation. Standardisation of the calculated values was not needed as 
they were compared with those values derived from control subjects obtained 
using the same procedure. 
 
We chose to use geometrical ROIs to easily quantify the different regions of the 
putamen and obtain a variety of indexes to help in the study. This type of ROIs do 
not require a very accurate spatial normalisation of the SPECT images to the 
template, in contrast with the anatomical ROIs derived from the AAL map applied 
in chapter 6. Due to their simplicity and versatility, geometrical ROIs are commonly 
used to quantify images in clinical routine (Walker et al 2002, Varrone et al 2004, 
Mateos et al 2005). 
 
In this longitudinal study, no differences were found in either overall striatal DAT 
binding or binding in striatal subregions (left and right caudate and putamen) over 
time between patients and controls. However, smaller differences in DAT binding 
over time were found in those patients with more negative symptoms at follow-up. 
 
In this work, a clinical situation with real studies, both pathological and normal, 
was addressed with the use of the semi-quantification methodology presented in 












7.4 Decreased striatal dopamine transporter uptake and 
substantia nigra hyperechogenicity as risk markers of 
synucleinopathy in patients with idiopathic rapid-eye-
movement sleep behaviour disorder: a prospective 
study  
7.4.1 Aim of the study 
Iranzo et al in 2010 presented a prospective study assessing DAT uptake using 123I-
FP-CIT SPECT and echogenicity of the substantia nigra by use of transcranial 
sonography (TCS) in identified patients with idiopathic rapid-eye-movement sleep 
behaviour disorder (IRBD). IRBD patients can develop synucleinopathies 
associated with substantia nigra dysfunction such as PD, dementia with Lewy 
bodies and multiple system atrophy but, until present, identification of which 
patients with IRBD will develop these disorders is unknown. The authors 
hypothesised that neuroimaging findings such as decreased DAT uptake and 
midbrain hyperechogenicity, which are typical of early PD, might also occur in some 
patients with IRBD, who might then be at increased risk for development of a 
neurological syndrome. 
 
7.4.2 Materials and methods 
To prove this hypothesis, the authors carried out a prospective study with 43 
patients with IRBD. Patients had both DAT imaging and TCS at baseline, and two 
and a half years later the number of patients who had developed a 
neurodegenerative syndrome was assessed. Results obtained from IRBD patients 
were compared with a group of healthy controls (18 controls for DAT imaging and 
149 for TCS). 
 
SPECT studies were acquired with a Siemens E.CAM gamma camera equipped with 
a LEHR collimator (see chapter 5 for a detailed description of the imaging system) 
and using 123I-FP-CIT. SPECT images were reconstructed using FBP with a 
Butterworth filter and attenuation compensation using the Chang’s method. 
 
We quantified the SPECT images using a 123I-FP-CIT SPECT template and a template 
of ROIs generated using the same methodology as in Mané et al 2011, which is 
described in section 7.3.2. 
 





Evaluation of the calculated ratios was performed by comparison with those values 
corresponding to control subjects obtained using the same imaging system and 
following the same acquisition, reconstruction and quantification protocols. The 
specific striatal-to-occipital cortex uptake ratio was regarded as pathological when 




As in the previous clinical work, 123I-FP-CIT SPECT images were processed in our 
laboratory using geometrical ROIs defined on a template. Since calculated values 
were compared with those values derived from control subjects obtained using the 
same procedure, standardisation of the measured values was not required. 
 
This prospective study showed that only those patients with reduced DAT uptake 
or midbrain hyperechogenicity at baseline developed a synucleinopathy. On this 
basis, the authors suggested that combined DAT imaging and TCS is a potential 
strategy for early identification of IRBD individuals who are at increased short-term 
risk for development of synucleinopathies such as PD, dementia with Lewy bodies 
or multiple system atrophy. 
 
In this clinical work, the main steps of the semi-quantification methodology 
presented in this doctoral dissertation were adapted to the resources and image 
processing programs available in a real clinical situation, finding a suitable 





































1. The SimSET MC code was adapted for the simulation of SPECT studies with 123I-
labelled radioligands. Once validated by comparing simulated and experimental 
projections of the anthropomorphic striatal phantom, it was used to simulate 
dopaminergic neurotransmission 123I SPECT studies with different gamma 
cameras and collimators. The simulated projections obtained using the modified 
SimSET allow us to conclude that: 
 
a) An emission model which considers the low-energy line at 159 keV with a 
yield of 97% and one single high-energy line at 529 keV with a yield of 3%, 
permits the user to accurately simulate 123I SPECT studies. 
b) The scatter contribution is strongly dependent on the imaging system 
employed, with values ranging from 43% for a Elscint HELIX gamma 
camera equipped with a LEHR fan-beam collimator to 51% for a Siemens 
E.CAM gamma camera equipped with a LEHR parallel collimator. 
 
2. A new quantification method to provide absolute quantification in dopaminergic 
neurotransmission SPECT studies with 123I was developed. The comparison 
between calculated and true SUR values derived from simulated studies showed 
that: 
 
a) Calculated SUR values depend on the imaging system when the 
quantification method does not include compensation for all degrading 
phenomena. However, a linear relationship between calculated and true 
SUR values was found regardless of the corrections applied. 





b) PVE compensation plays a major role in the recovery of the true values. 
The proposed MC-based scatter compensation also plays an important part 
while PSF and attenuation corrections are the least significant. 
c) The new quantification method, which includes compensation for all 
degradations, allows the theoretical SUR values to be reached, thereby 
enabling absolute quantification. 
 
3. A methodology was developed to provide standardised semi-quantitative values 
in dopaminergic neurotransmission SPECT studies with 123I in a clinical context. 
The comparison between calculated and true SUR values derived from 
simulated studies showed that: 
 
a) Inter-subject anatomical variability does not compromise the general linear 
model between calculated and true values for any of the quantification 
methods applied in the study (ROIs derived from MRI and generic ROIs 
derived from the AAL map). 
b) A simple linear model can be used to obtain standardised SUR values, 
although a multiple linear model which specifically accounts for the 
influence of PVE provides slightly higher accuracy and lower variability. 
c) Reconstruction and quantification methods have a high impact on the 
linearity of the relationship between calculated and true values and on the 
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